This is a Validated Antibody Database (VAD) review about human granzyme B, based on 303 published articles (read how Labome selects the articles), using granzyme B antibody in all methods. It is aimed to help Labome visitors find the most suited granzyme B antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
granzyme B synonym: C11; CCPI; CGL-1; CGL1; CSP-B; CSPB; CTLA1; CTSGL1; HLP; SECT

Invitrogen
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...
Invitrogen granzyme B antibody (Thermo Fisher, MA1-80734) was used in flow cytometry on mouse samples . Cancer Cell (2021) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; 1:100; loading ...; fig 5a
Invitrogen granzyme B antibody (Invitrogen, MHGB04) was used in flow cytometry on mouse samples at 1:100 (fig 5a). Nat Commun (2021) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:200; loading ...
Invitrogen granzyme B antibody (eBioscience, GB11) was used in flow cytometry on mouse samples at 1:200. Nat Commun (2021) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; loading ...; fig 7j
Invitrogen granzyme B antibody (Thermo Fisher, MHGB04) was used in flow cytometry on mouse samples (fig 7j). Cell Rep Med (2021) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; 1:100; loading ...; fig s7b
Invitrogen granzyme B antibody (Thermo Fisher, MHGB05) was used in flow cytometry on mouse samples at 1:100 (fig s7b). Science (2021) ncbi
mouse monoclonal (GB11)
  • immunocytochemistry; human; 10 ug/ml; loading ...; fig 6v1
Invitrogen granzyme B antibody (Thermo Scientific, MA1-80734) was used in immunocytochemistry on human samples at 10 ug/ml (fig 6v1). elife (2021) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; 1:100; loading ...
Invitrogen granzyme B antibody (Thermo Fisher Scientific, GB12) was used in flow cytometry on mouse samples at 1:100. elife (2020) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; 1:2000; loading ...
Invitrogen granzyme B antibody (Invitrogen, GRB18) was used in flow cytometry on human samples at 1:2000. bioRxiv (2020) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; 1:40; loading ...; fig 2s1
Invitrogen granzyme B antibody (Thermo, GRB17) was used in flow cytometry on human samples at 1:40 (fig 2s1). elife (2020) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 4a
Invitrogen granzyme B antibody (eBioscience, GB11) was used in flow cytometry on human samples (fig 4a). BMC Immunol (2020) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 2f
Invitrogen granzyme B antibody (Thermofisher, GRB17) was used in flow cytometry on mouse samples (fig 2f). Immunity (2019) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig s4f
Invitrogen granzyme B antibody (Invitrogen, GRB18) was used in flow cytometry on mouse samples (fig s4f). Cell (2019) ncbi
mouse monoclonal (GB11)
  • other; human; 1:25; loading ...; fig 2f
Invitrogen granzyme B antibody (ThermoFisher Scientific, MA1-80734) was used in other on human samples at 1:25 (fig 2f). elife (2019) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; loading ...; fig s1g
Invitrogen granzyme B antibody (Invitrogen, MHGB04) was used in flow cytometry on human samples (fig s1g). Cell (2019) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; loading ...; fig 6f
Invitrogen granzyme B antibody (Invitrogen, MHGB04) was used in flow cytometry on mouse samples (fig 6f). PLoS Pathog (2018) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 2f
Invitrogen granzyme B antibody (Thermo Fisher, GB11) was used in flow cytometry on human samples (fig 2f). Front Immunol (2018) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; loading ...; fig 4b
Invitrogen granzyme B antibody (Invitrogen, GB12) was used in flow cytometry on mouse samples (fig 4b). J Virol (2018) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 3b
Invitrogen granzyme B antibody (eBioscience, GB11) was used in flow cytometry on human samples (fig 3b). J Exp Med (2018) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; fig 1b
In order to study the involvement of Notch signaling in NK cell lineage determination, Invitrogen granzyme B antibody (invitrogen, GB12) was used in flow cytometry on human samples (fig 1b). J Immunol (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 3a
In order to evaluate the role of IL-32alpha in NK cell inhibition, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on human samples (fig 3a). J Immunol (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 3d
In order to evaluate the effectiveness of adoptive natural killer cell therapy against the pulmonary metastasis of Ewing sarcoma, Invitrogen granzyme B antibody (eBiosciences, GB11) was used in flow cytometry on human samples (fig 3d). Oncoimmunology (2017) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; fig 5b
In order to find that TLR3, 7 and 9 deficiencies on host cells result in complete tumor regression and induction of anti-tumor immunity, Invitrogen granzyme B antibody (Life Technologies, GB12) was used in flow cytometry on mouse samples (fig 5b). Nat Commun (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 3f
In order to investigate origin of tumor-infiltrating T regulatory cells in breast cancer samples, Invitrogen granzyme B antibody (Thermo fischer scientific, 12-8899) was used in flow cytometry on human samples (fig 3f). Cell Res (2017) ncbi
mouse monoclonal (GB12)
  • flow cytometry; African green monkey; loading ...; fig s4
In order to optimize the dosing regimen of neutralizing anti-HIV-1 antibodies, Invitrogen granzyme B antibody (invitrogen, GB12) was used in flow cytometry on African green monkey samples (fig s4). Nature (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 3a
In order to use CD49a expression to define subsets of tissue-resident memory T cells in the skin, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on human samples (fig 3a). Immunity (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:125; loading ...; fig 3h
In order to evaluate the use of a recombinant Newcastle disease virus expressing ICOS ligand to treat cancer, Invitrogen granzyme B antibody (Invitrogen, GRB05) was used in flow cytometry on mouse samples at 1:125 (fig 3h). Nat Commun (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 6m
In order to investigate the mechanisms by which eomesodermin regulates memory fitness in T cells, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples (fig 6m). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 3c
In order to examine the potential of IL-2 to enhance T regulatory cell therapy, Invitrogen granzyme B antibody (eBioscience, GB11) was used in flow cytometry on human samples (fig 3c). Clin Exp Immunol (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, Invitrogen granzyme B antibody (LifeTechnologies/Invitrogen, GB11) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (GB12)
  • flow cytometry; rhesus macaque; loading ...; fig 6d
In order to discuss the assessment of species cross-reactive human agents in large animal graft-versus-host disease models, Invitrogen granzyme B antibody (Invitrogen, MHGB05) was used in flow cytometry on rhesus macaque samples (fig 6d). Transplantation (2016) ncbi
mouse monoclonal (GB12)
  • flow cytometry; rhesus macaque; fig 4d
In order to examine the contribution of HIV-derived conserved elements in vaccination, Invitrogen granzyme B antibody (Invitrogen, GB12) was used in flow cytometry on rhesus macaque samples (fig 4d). J Immunol (2016) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; loading ...; fig 4a
In order to characterize CD8 positive T cell subsets in dengue patients from India and Thailand, Invitrogen granzyme B antibody (Invitrogen, MHGB04) was used in flow cytometry on human samples (fig 4a). J Virol (2016) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; loading ...; fig 5f
In order to investigate the contribution of TGF-beta to the eomesodermin-driven CD4 T cell program during viral infection, Invitrogen granzyme B antibody (Invitrogen, GB12) was used in flow cytometry on mouse samples (fig 5f). J Clin Invest (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 7
In order to study the functions of WASp knock out natural killer cells, Invitrogen granzyme B antibody (Invitrogen, GRB17) was used in flow cytometry on human samples (fig 7). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; fig 3
  • western blot; human; fig 3
In order to investigate the functions of EZH2 in human T cells, Invitrogen granzyme B antibody (Thermo, PA5-17457) was used in immunocytochemistry on human samples (fig 3) and in western blot on human samples (fig 3). Cell Death Dis (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 4i
In order to assess the contribution of interferon-induced transmembrane protein 3 to West Nile virus infection, Invitrogen granzyme B antibody (Invitrogen, GRB04) was used in flow cytometry on mouse samples (fig 4i). J Virol (2016) ncbi
mouse monoclonal (GZB01)
  • immunohistochemistry; human; 1:50; fig 3
In order to characterize anti-GABAB receptor limbic encephalitis and evidence of a pathogenic role for CD8(+) T cells, Invitrogen granzyme B antibody (Thermo, MS-1157-S1) was used in immunohistochemistry on human samples at 1:50 (fig 3). Neurol Neuroimmunol Neuroinflamm (2016) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; 1:100; fig 3
In order to elucidate the marked reduction of Nkp44/Nkp46-double positive natural killer cells by celiac disease-related inflammation, Invitrogen granzyme B antibody (Invitrogen, GB12) was used in flow cytometry on human samples at 1:100 (fig 3). PLoS ONE (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 1
In order to characterize mediation of anti-viral cytotoxicity by type 1 interferon licenses naive CD8 T cells, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples (fig 1). Virology (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse
In order to examine the contribution of Foxo1 to activated T cells, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples . Nature (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:50; fig 5
In order to elucidate restriction of west nile virus infection and pathogenesis in a region-specific and cell-type manner by the interferon-stimulated gene Ifi2712a, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples at 1:50 (fig 5). J Virol (2015) ncbi
rat monoclonal (16G6)
  • western blot; human; loading ...; fig 2c
Invitrogen granzyme B antibody (eBioscience, 16G6) was used in western blot on human samples (fig 2c). J Biol Chem (2016) ncbi
mouse monoclonal (GZB01)
  • immunohistochemistry - paraffin section; human; 1:1000
In order to compare multiple sclerosis to autoimmune encephalitis in humans, Invitrogen granzyme B antibody (Neomarkers, MS-1157-S) was used in immunohistochemistry - paraffin section on human samples at 1:1000. Acta Neuropathol Commun (2015) ncbi
rat monoclonal (16G6)
  • flow cytometry; mouse
In order to study PI3Kdelta in CD8+ T cells during infection with Listeria monocytogenes, Invitrogen granzyme B antibody (eBioscience, 16G6) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 2f
In order to test if anti-retroviral natural killer cell functions are inhibited by T regulatory cells during an acute Friend retrovirus infection, Invitrogen granzyme B antibody (Life technologies, GB11) was used in flow cytometry on mouse samples (fig 2f). Retrovirology (2015) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; fig 5
In order to evaluate as a mucosal vaccine platform against influenza A virus, Invitrogen granzyme B antibody (Invitrogen, #MHGB05) was used in flow cytometry on human samples (fig 5). Front Immunol (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 10a
In order to determine if therapeutic antiviral T cells eliminate viral load in the brain of mice persistently infected from birth with lymphocytic choriomeningitis virus without causing blood-brain barrier breakdown or tissue damage, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples (fig 10a). J Exp Med (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 2
In order to study engineered anti-melanoma vaccines that modulate cytokine priming and silence PD-L1 simultaneously by use of ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy, Invitrogen granzyme B antibody (Invitrogen, GRB05) was used in flow cytometry on mouse samples (fig 2). Oncoimmunology (2014) ncbi
mouse monoclonal (GZB01)
  • immunohistochemistry - paraffin section; human
In order to describe the clinicopathological features of 15 patients with Epstein-Barr virus-positive nodal T/NK-cell lymphoma, Invitrogen granzyme B antibody (Thermo Scientific, GZB01) was used in immunohistochemistry - paraffin section on human samples . Hum Pathol (2015) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse
In order to investigate the differentiation and function of murine gamma-herpesvirus 68 (MHV-68)-specific CD4(+) T cells using gp150-specific TCR-transgenic mice, Invitrogen granzyme B antibody (Invitrogen, GB12) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 1
In order to investigate the role of granzyme B in T regulatory cell resistance, Invitrogen granzyme B antibody (eBioscience, GB11) was used in flow cytometry on human samples (fig 1). J Immunol (2015) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse
Invitrogen granzyme B antibody (Invitrogen, GB12) was used in flow cytometry on mouse samples . Cancer Immunol Res (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; dogs
Invitrogen granzyme B antibody (eBioscience, GB11) was used in flow cytometry on dogs samples . Vet Res Commun (2015) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse
In order to study CD4 and CD8 responses to L. monocytogenes using GZMB-Tom knock-in mice, Invitrogen granzyme B antibody (Invitrogen, MHGB05) was used in flow cytometry on mouse samples . Immunology (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse
In order to examine the role of GPR18 in intestinal intraepithelial lymphocytes, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 5
In order to investigate the effect of SGI-110 on cancer testis antigen gene-regulated expression, Invitrogen granzyme B antibody (Invitrogen, clone GB11) was used in flow cytometry on human samples (fig 5). Leuk Res (2014) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 7
In order to determine virus-induced immune suppression of CD8 T cell responses caused by out-of-sequence signal 3, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples (fig 7). PLoS Pathog (2014) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse
In order to investigate the role of T reg cells in exhaustion of lymphocytic choriomeningitis virus-specific CD8 T cells, Invitrogen granzyme B antibody (Invitrogen, MHGB04) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 2
In order to show that MID1 regulates cytotoxic lymphocytes responses, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples (fig 2). Eur J Immunol (2014) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human
In order to developed a strategy to expand umbilical cord blood T cells and test their effects after transplantation, Invitrogen granzyme B antibody (eBioscience, GB11) was used in flow cytometry on human samples . Leukemia (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse
In order to investigate incomplete immunity against intracellular pathogens in neonates, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse
In order to study the role of human endogenous retrovirus (HERV) envelope proteins in the uptake of exosomes, Invitrogen granzyme B antibody (Invitrogen, GB12) was used in flow cytometry on mouse samples . FASEB J (2014) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse
In order to characterize early inflammation at the feeding site of infected sand flies in mice protected from vector-transmitted Leishmania major by exposure to uninfected bites, Invitrogen granzyme B antibody (Invitrogen, GRB05) was used in flow cytometry on mouse samples . PLoS Negl Trop Dis (2014) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse
In order to demonstrate that CTLA-4 promotes Tc17 differentiation and robust Tc17 responses, Invitrogen granzyme B antibody (Caltag Laboratories, MHGB04) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse
In order to study the effect of FTY720 treatment on CD8 T-cells, Invitrogen granzyme B antibody (Invitrogen, MHGB04) was used in flow cytometry on mouse samples . J Neuroimmunol (2014) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human
In order to quantify coexpression of different killer Ig-like molecules in patient natural killer cells with mutant TAP genes mediating deficient HLA class I expression, Invitrogen granzyme B antibody (Invitrogen, FGB12) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human
In order to assess T regulatory type 1 cell therapy in patients with high-risk/advanced stage hematologic malignancies, Invitrogen granzyme B antibody (Caltag, GB11) was used in flow cytometry on human samples . Front Immunol (2014) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human
Invitrogen granzyme B antibody (Invitrogen, clone GB11) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human
In order to investigate the effect of CpG and IL-21 treatment on B-cell chronic lymphocytic leukemia, Invitrogen granzyme B antibody (Invitrogen, GB12) was used in flow cytometry on human samples . Int Immunol (2014) ncbi
mouse monoclonal (GB12)
  • flow cytometry; rhesus macaque
In order to compare vaccination with highly conserved gag elements verses full-length gag DNA, Invitrogen granzyme B antibody (Invitrogen, GB12) was used in flow cytometry on rhesus macaque samples . PLoS ONE (2014) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse
In order to characterize the Treg populations the Friend retrovirus mouse model, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples . Virol Sin (2014) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse
Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
mouse monoclonal (GB11)
  • immunocytochemistry; human; fig 1
  • western blot; human; fig 1
In order to identify ADP-ribosylation factor-like 8b as a factor required for natural killer cell-mediated cytotoxicity, Invitrogen granzyme B antibody (Caltag, GB11) was used in immunocytochemistry on human samples (fig 1) and in western blot on human samples (fig 1). Mol Biol Cell (2013) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse
In order to optimize the CD8 T cell-inducing capacity of modified vaccinia Ankara, Invitrogen granzyme B antibody (Life Technologies, GRB04) was used in flow cytometry on mouse samples . Front Immunol (2013) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; fig 2
In order to examine the functional effects of regulatory T cells during A2-strain respiratory syncytial virus infection, Invitrogen granzyme B antibody (Invitrogen, GB12) was used in flow cytometry on mouse samples (fig 2). J Virol (2013) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; fig 1
In order to assess the role of aryl hydrocarbon receptor nuclear translocator in intestinal intraepithelial T cells development, Invitrogen granzyme B antibody (Life Technologies, MHGB05) was used in flow cytometry on mouse samples (fig 1). Nat Commun (2013) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 2
In order to report that FoxO1 regulates effector-to-memory transition and functional maturation of memory CD4 and CD8 T cells, Invitrogen granzyme B antibody (Invitrogen, clone GB11) was used in flow cytometry on mouse samples (fig 2). J Immunol (2013) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 5
In order to determine the generation, phenotype, and function of IL-10-producing CD8(+) T cells in mice infected with murine gamma-herpesvirus-68, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples (fig 5). J Immunol (2013) ncbi
mouse monoclonal (GZB01)
  • immunohistochemistry - paraffin section; human; 1:1000
In order to investigate the mechanisms that lead to demyelination and neurodegeneration, Invitrogen granzyme B antibody (Neomarkers, MS-1157-S) was used in immunohistochemistry - paraffin section on human samples at 1:1000. Brain (2013) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 4
In order to investigate the suppressive activity of Tregs on effector CD4(+) T cells in retroviral infection, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples (fig 4). J Virol (2013) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; fig 2
In order to conclude that increased detection of granzyme B in cytotoxic T cells and natural killer cells is an immune signature for lymphocyte activation in hemophagocytic lymphohistiocytosis, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on human samples (fig 2). Front Immunol (2013) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 2
In order to study the pulmonary immune response to Francisella tularensis, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples (fig 2). Microbes Infect (2013) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 2
In order to examine how NK cells integrate signals induced by stress and antibody-coated cells, Invitrogen granzyme B antibody (Caltag, GB11) was used in flow cytometry on mouse samples (fig 2). J Immunol (2012) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse
In order to study T cell responses elicited by Ad5 and those of alternative-serotype Ad vectors, Invitrogen granzyme B antibody (Invitrogen, MHGB04) was used in flow cytometry on mouse samples . J Virol (2013) ncbi
mouse monoclonal (GB12)
  • flow cytometry; rhesus macaque; fig 4
In order to study the use of an IL-12 adjuvant when vaccinating rhesus macaques, Invitrogen granzyme B antibody (Invitrogen, MHGB04) was used in flow cytometry on rhesus macaque samples (fig 4). Hum Vaccin Immunother (2012) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 3
In order to study the role of IL-15 and IL-7 on CD8 T cells during infection with Toxoplasma gondii, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples (fig 3). Microbes Infect (2012) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; 1:50; fig 2
In order to study TLR7 knockout mice infected with lymphocytic choriomeningitis virus, Invitrogen granzyme B antibody (Invitrogen, MHGB04) was used in flow cytometry on mouse samples at 1:50 (fig 2). Cell Host Microbe (2012) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 4
In order to study CD8(+) T cell homeostasis and CD8-mediated autoimmunity, Invitrogen granzyme B antibody (Invitrogen, clone GB11) was used in flow cytometry on mouse samples (fig 4). J Immunol (2012) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse
In order to elucidate how TGF-beta signaling regulates the self-reactivity of peripheral T cells, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples . Nat Immunol (2012) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse
In order to identify a new population of CD8(+)FoxP3(+) T(reg), Invitrogen granzyme B antibody (Invitrogen, MHGB05) was used in flow cytometry on mouse samples . Blood (2012) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 5
In order to study HIV-specific CD8 T cells, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on human samples (fig 5). Blood (2012) ncbi
mouse monoclonal (GB11)
  • flow cytometry; rhesus macaque; loading ...; fig 4a
In order to optimize a DNA vaccine to boost cellular immune responses induced by Ad5 prime, Invitrogen granzyme B antibody (Invitrogen, GRB11) was used in flow cytometry on rhesus macaque samples (fig 4a). Vaccine (2012) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse
In order to study the contribution of IL-10 in mice infected with respiratory syncytial virus, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on mouse samples . PLoS ONE (2012) ncbi
mouse monoclonal (GB11)
  • flow cytometry; African green monkey; fig 6
In order to elucidate immune mechanisms that facilitate viral clearance and contribute to persistent lung inflammation following SARS-CoV infection, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on African green monkey samples (fig 6). J Virol (2012) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse
In order to report the effect of T regulatory cell depletion during acute respiratory syncytial virus infection, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on mouse samples . Mucosal Immunol (2012) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; fig 2
In order to determine the role of granzyme B in immune regulation during viral infections, Invitrogen granzyme B antibody (Invitrogen, GB12) was used in flow cytometry on mouse samples (fig 2). J Immunol (2011) ncbi
rat monoclonal (16G6)
  • flow cytometry; mouse
In order to report coreceptor gene imprinting as a critical determinant of lineage fate determination in the thymus, Invitrogen granzyme B antibody (eBioscience, 16G6) was used in flow cytometry on mouse samples . EMBO J (2012) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human
In order to determine the role for DOCK8 in peripheral CD8 T cell survival and function, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on human samples . J Exp Med (2011) ncbi
mouse monoclonal (GB11)
  • flow cytometry; rhesus macaque; fig 2
In order to characterize different macaque NK cell subpopulations, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on rhesus macaque samples (fig 2). Immunology (2011) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 3
In order to elucidate the role of TRAIL in the pulmonary CD8 T cell response to influenza A virus, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples (fig 3). J Immunol (2011) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; fig 3
In order to examine the HA-specific T-cell responses among a cohort of young and elderly influenza vaccines, Invitrogen granzyme B antibody (Caltag, clone GB12) was used in flow cytometry on human samples (fig 3). Vaccine (2011) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; fig 1
In order to elucidate the protective role of CD8(+) T cells against Histoplasma capsulatum, Invitrogen granzyme B antibody (Caltag, MHGB04) was used in flow cytometry on mouse samples (fig 1). Infect Immun (2011) ncbi
mouse monoclonal (GZB01)
  • immunohistochemistry; human; fig 3
In order to study subcutaneous panniculitis-like T-cell lymphomas in Korean patients, Invitrogen granzyme B antibody (NeoMarkers, GZB01) was used in immunohistochemistry on human samples (fig 3). Ann Dermatol (2011) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; fig 3
In order to examine red blood cells as an immunogen, Invitrogen granzyme B antibody (Invitrogen, GB12) was used in flow cytometry on mouse samples (fig 3). Am J Transplant (2011) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 4
In order to suggest that PD-1 expression during acute infection is not a marker of T cell exhaustion, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples (fig 4). J Immunol (2011) ncbi
mouse monoclonal (GZB01)
  • immunohistochemistry; human; 1:50; fig 5I
In order to examine tumor and nonadjacent normal breast tissue from women with breast cancer, who either had or had not received neoadjuvant chemotherapy before surgery, Invitrogen granzyme B antibody (Thermo Scientific, MS-1157-S1) was used in immunohistochemistry on human samples at 1:50 (fig 5I). Proc Natl Acad Sci U S A (2012) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; fig 5
In order to study the effects of type I-interferon on graft verses host disease, Invitrogen granzyme B antibody (Invitrogen, MHGB05) was used in flow cytometry on mouse samples (fig 5). Blood (2011) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; fig 2
In order to examine the effect of n-3 PUFA-docosahexaenoic acid bladder and pancreatic cancer cells, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on human samples (fig 2). J Nutr Biochem (2012) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; fig 6
In order to examine the impact of neutrophils on CD8 positive T-cell responses during influenza virus infection, Invitrogen granzyme B antibody (Caltag, MHGB05) was used in flow cytometry on mouse samples (fig 6). Immunol Cell Biol (2012) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 3
In order to study the contribution of the cellular immune response in maintaining nonpathogenic SIV infection in sooty mangabeys, Invitrogen granzyme B antibody (Invitrogen, clone GB11-PETxRed) was used in flow cytometry on human samples (fig 3). J Immunol (2011) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; fig 2
In order to investigate the role of CD8 T cells to the brain and liver damage observed during infection with Plasmodium berghei ANKA, Invitrogen granzyme B antibody (Caltag Laboratories, GB12) was used in flow cytometry on mouse samples (fig 2). Infect Immun (2011) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; fig 4
In order to examine the IRF4-Blimp1-Bcl6 regulatory axis in NK development, Invitrogen granzyme B antibody (Invitrogen, GB12) was used in flow cytometry on mouse samples (fig 4). Blood (2011) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; fig 5, 6
In order to report that NAD(+) regulates the survival, phenotype, and function of T regulatory cells via the ART2-P2X7 pathway, Invitrogen granzyme B antibody (Invitrogen, GB12) was used in flow cytometry on mouse samples (fig 5, 6). J Exp Med (2010) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; fig 4
In order to test if selective depletion of Foxp3(+) Tregs reduces cancer, Invitrogen granzyme B antibody (Invitrogen, GB12) was used in flow cytometry on mouse samples (fig 4). Cancer Res (2010) ncbi
mouse monoclonal (GB12)
  • flow cytometry; rhesus macaque; fig 6
In order to investigate immune mechanisms responsible for viral control in Indian rhesus macaques infected SIV, Invitrogen granzyme B antibody (Invitrogen, GB12) was used in flow cytometry on rhesus macaque samples (fig 6). J Immunol (2010) ncbi
rat monoclonal (16G6)
  • flow cytometry; mouse; fig 2, 3
In order to report sex-dependent, B7-H1-dependent differences in tumor immunity, Invitrogen granzyme B antibody (eBioscience, 16G6) was used in flow cytometry on mouse samples (fig 2, 3). J Immunol (2010) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; fig 6
In order to investigate the function of the Vaccinia virus A47L gene, Invitrogen granzyme B antibody (Invitrogen, clone GB12) was used in flow cytometry on human samples (fig 6). J Virol (2010) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; fig 3
In order to identify immunologic correlates of immune reconstitution inflammatory syndrome in HIV patients, Invitrogen granzyme B antibody (Caltag, clone GB12) was used in flow cytometry on human samples (fig 3). Blood (2010) ncbi
mouse monoclonal (GB12)
  • flow cytometry; African green monkey; fig 5
In order to characterize natural killer T subsets in sooty mangabey, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on African green monkey samples (fig 5). J Med Primatol (2010) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; fig 4
In order to study Vgamma2Vdelta2 T cells from Caucasian or African American donors, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on human samples (fig 4). Hum Immunol (2010) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; fig s2
In order to investigate the different immune responses when mice are infected with type I or type II strains of T. gondii, Invitrogen granzyme B antibody (Invitrogen, GB12) was used in flow cytometry on mouse samples (fig s2). J Immunol (2010) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 2
In order to investigate how bystander CD8 cells are impacted during viral infection, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples (fig 2). J Immunol (2010) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 6
In order to use a transgenic mouse model of spontaneous astrocytoma to study immune infiltrate, Invitrogen granzyme B antibody (Caltag, GB11) was used in flow cytometry on mouse samples (fig 6). Cancer Res (2010) ncbi
mouse monoclonal (GB12)
  • flow cytometry; rhesus macaque; fig 5
In order to investigate changes to macaque NK-cell subsets during infection with SIV, Invitrogen granzyme B antibody (Invitrogen, GB12) was used in flow cytometry on rhesus macaque samples (fig 5). Blood (2010) ncbi
mouse monoclonal (GB11)
  • immunocytochemistry; human
In order to investigate the effect of perforin on specific endocytosis process, Invitrogen granzyme B antibody (Caltag Laboratories, GB11) was used in immunocytochemistry on human samples . Blood (2010) ncbi
rat monoclonal (16G6)
  • flow cytometry; mouse; fig 2e
In order to assess the consequences of phosphoinositide (3,4,5)-triphosphate binding to 3-phosphoinositide-dependent kinase 1, Invitrogen granzyme B antibody (eBioscience, 16G6) was used in flow cytometry on mouse samples (fig 2e). Mol Cell Biol (2009) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse
In order to study the influence of Treg on pathogen-specific CD8+ T-cell responses in vivo, Invitrogen granzyme B antibody (Caltag Laboratories, GB12) was used in flow cytometry on mouse samples . Blood (2009) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; fig 1
In order to identify conditions in which granzyme B is produced by human B cells, Invitrogen granzyme B antibody (Invitrogen, GB12) was used in flow cytometry on human samples (fig 1). J Immunol (2009) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse
In order to examine granzyme expression during influenza infection, Invitrogen granzyme B antibody (Caltag, MHGB05) was used in flow cytometry on mouse samples . Eur J Immunol (2009) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 1
In order to explore how naive CD4 cells differentiate into class II restricted killers, Invitrogen granzyme B antibody (Caltag, GB11) was used in flow cytometry on mouse samples (fig 1). Cell Immunol (2009) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human
In order to characterize peripheral natural killer cells in patients with rheumatoid arthritis, Invitrogen granzyme B antibody (Caltag Laboratories, GRB04) was used in flow cytometry on human samples . Mod Rheumatol (2009) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 5b
In order to elucidate the role of IL-17 in influenza A infection, Invitrogen granzyme B antibody (Caltag Laboratories, GB11) was used in flow cytometry on mouse samples (fig 5b). J Immunol (2009) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse
In order to study the role of the transcription regulator CCCTC-binding factor in Th2 differentiation, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on mouse samples . J Immunol (2009) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human
In order to elucidate the role of interleukin-15 in human natural killer cell development, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on human samples . J Exp Med (2009) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 5
In order to determine the importance of TRAIL to influenza-specific CD8(+) T cell immunity and control of the infection, Invitrogen granzyme B antibody (Invitrogen, GB11) was used in flow cytometry on human samples (fig 5). J Immunol (2008) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse
In order to measure effector gene expression early after CTL activation, Invitrogen granzyme B antibody (Caltag Laboratories, GB12) was used in flow cytometry on mouse samples . J Immunol (2008) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; tbl 1
In order to characterize Tregs from older subjects and mice, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on human samples (tbl 1). J Immunol (2008) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; fig 1
In order to study Vgamma2Vdelta2 T cells in HIV infected patients, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on human samples (fig 1). J Leukoc Biol (2008) ncbi
mouse monoclonal (GB12)
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 1
In order to test the efficacy of DNA vaccination with anaplastic lymphoma kinase in a mouse model of anaplastic large cell lymphoma, Invitrogen granzyme B antibody (Caltag, GB12) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 1). Nat Med (2008) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse
In order to analyze protection against Plasmodium berghei by a single-dose simian adenovirus vector using a human cytomegalovirus promoter containing intron A, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on mouse samples . J Virol (2008) ncbi
rat monoclonal (16G6)
  • flow cytometry; mouse; fig 4
In order to study how multifactorial adjuvants show reduced toxicity and enhanced efficacy compared to unitary adjuvants as cancer vaccines, Invitrogen granzyme B antibody (eBioscience, 16G6) was used in flow cytometry on mouse samples (fig 4). Blood (2008) ncbi
rat monoclonal (16G6)
  • flow cytometry; mouse
Invitrogen granzyme B antibody (eBioscience, 16G6) was used in flow cytometry on mouse samples . Nat Immunol (2008) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human
In order to test if granzyme B is produced in the myeloid cell lines HL-60 and U937, in CD34+ stem cells, and in PMN derived from CD34+ cells in vitro, Invitrogen granzyme B antibody (Caltag, Invitrogen,, GB12) was used in flow cytometry on human samples . Mol Immunol (2008) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse
In order to assess the contributions of viral replication levels in the induction and activation of cytotoxic T cells, Invitrogen granzyme B antibody (Caltag Laboratories, GB12) was used in flow cytometry on mouse samples . J Virol (2007) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; fig 1
In order to examine rhesus cytomegalovirus-specific CD8+ T lymphocytes, Invitrogen granzyme B antibody (Caltag, clone GB12) was used in flow cytometry on human samples (fig 1). J Immunol Methods (2007) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 3B
  • flow cytometry; human; fig 5C
In order to determine if clonal expansion and acquisition of effector functions driven by antigen presenting cells is reshaped during the effector phase to adapt to the effector site microenvironment in murine brain tumor models, Invitrogen granzyme B antibody (Invitrogen/ Life Technologies, GB11) was used in flow cytometry on mouse samples (fig 3B) and in flow cytometry on human samples (fig 5C). J Immunol (2007) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; fig 5
In order to explore how naive, effector, and memory T cells differ in cytotoxic potential, Invitrogen granzyme B antibody (Caltag Laboratories, GB12) was used in flow cytometry on mouse samples (fig 5). J Immunol (2007) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 7
In order to elucidate CTLA-4 regulation of cytotoxic T lymphocytes in a transgenic model of CD8+ T-cell-mediated myocarditis, Invitrogen granzyme B antibody (Caltag, GB11) was used in flow cytometry on mouse samples (fig 7). Circ Res (2007) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; fig 3
In order to elucidate the developmental relationship between natural killer subsets, Invitrogen granzyme B antibody (Caltag Laboratories, GB12) was used in flow cytometry on human samples (fig 3). J Immunol (2007) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 2
In order to report that NKT cells produce IL-21 and that IL-21 regulates NKT function, Invitrogen granzyme B antibody (Caltag Laboratories, GB11) was used in flow cytometry on mouse samples (fig 2). J Immunol (2007) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; fig 4
In order to investigate the role of JNK2 in CD8+ T cell response and effector functions, Invitrogen granzyme B antibody (CALTAG, MHGB04) was used in flow cytometry on mouse samples (fig 4). Eur J Immunol (2007) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; 1:200; fig 3A
In order to study CD4(+) CD25 (+) regulatory T cells in B-cell non-Hodgkin's lymphoma and attenuation of CD8(+) T-cell function, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on human samples at 1:200 (fig 3A). Cancer Res (2006) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse
In order to study CD8+ T cell responses during herpesvirus infection, Invitrogen granzyme B antibody (Caltag, GB11) was used in flow cytometry on mouse samples . J Virol (2006) ncbi
mouse monoclonal (GB12)
  • flow cytometry; rhesus macaque
In order to determine the frequency, phenotype, and function of peripheral CD4+ CD8+ T cells in rhesus macaques infected with simian immunodeficiency virus, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on rhesus macaque samples . Immunology (2006) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; fig 2
In order to test if perforin polymorphisms influence the progression of HIV infection, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on human samples (fig 2). Int J Immunogenet (2006) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; fig 4
In order to study interaction between CD4+CD25+ T cells and B cells, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on mouse samples (fig 4). Blood (2006) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 6
In order to study the effects of prolonged antigen exposure, Invitrogen granzyme B antibody (Caltag, GB11) was used in flow cytometry on mouse samples (fig 6). J Immunol (2006) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 3
In order to examine the role of T-bet in Valpha14i natural killer T cell function, Invitrogen granzyme B antibody (Caltag, GB11) was used in flow cytometry on mouse samples (fig 3). Blood (2006) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; tbl 1
In order to review characteristics of non-T, non-B cell CD4+CD56+ neoplasms with lymphoblastic morphology, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on human samples (tbl 1). Eur J Haematol (2005) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; fig 5
In order to evaluate the use of a bispecific antibody to treat human Ep-CAM-overexpressing carcinomas, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on human samples (fig 5). Mol Immunol (2006) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse
In order to evaluate the tuberculosis vaccine candidate Mtb72F, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on mouse samples . Infect Immun (2005) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; tbl 2
In order to use flow cytometry to study granzyme A, B, and K expression in human peripheral blood lymphocytes, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on human samples (tbl 2). Eur J Immunol (2005) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; fig 5B
In order to examine impairment of cytotoxic CD8+ T-cell effector function during chronic Friend virus infection, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on mouse samples (fig 5B). J Virol (2005) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 2
In order to evaluate the therapeutic potential of different tumor-reactive CD8+ T cell memory subsets in vivo, Invitrogen granzyme B antibody (Caltag, GB11) was used in flow cytometry on mouse samples (fig 2). Proc Natl Acad Sci U S A (2005) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human
In order to analyze triplets infected with HHV-8 and the development of hemophagocytic lymphohistiocytosis, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on human samples . Blood (2005) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; fig 5
In order to analyze ocular herpes simplex virus-1 infection and the migration and development of protective CD8+ T cells into the nervous system, Invitrogen granzyme B antibody (Caltag Laboratories, GB12) was used in flow cytometry on mouse samples (fig 5). J Immunol (2005) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; 1:200; fig 1
In order to investigate the role of granzyme B in T regulatory cell-mediated suppression, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on mouse samples at 1:200 (fig 1). J Immunol (2005) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; fig 3A
In order to assess the impact of nucleotide synthesis inhibition on CD8 T cell differentiation, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on mouse samples (fig 3A). J Immunol (2004) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; fig 1
In order to report that human neutrophils lack granzyme A, granzyme B, and perforin, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on human samples (fig 1). Blood (2004) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; 1:400
  • flow cytometry; mouse; 1:400
In order to study granzymes A and B and differential expression in human cytotoxic lymphocyte subsets and T regulatory cells, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on human samples at 1:400 and in flow cytometry on mouse samples at 1:400. Blood (2004) ncbi
mouse monoclonal (GB12)
  • flow cytometry; mouse; fig 1
In order to investigate the role of cytotoxic effector-memory CD8(+) T cell during persistent viral infection, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on mouse samples (fig 1). J Immunol (2003) ncbi
mouse monoclonal (GB12)
  • flow cytometry; human; 10 ug/ml
In order to assess genetic variation in granzyme B, Invitrogen granzyme B antibody (Caltag, GB12) was used in flow cytometry on human samples at 10 ug/ml. Proc Natl Acad Sci U S A (2003) ncbi
mouse monoclonal (GrB-7)
  • immunohistochemistry - paraffin section; human
In order to measure granzyme A and B expression in non-pathological lymphoid tissue and peripheral blood lymphocyte subpopulations, Invitrogen granzyme B antibody (noco, GrB-7) was used in immunohistochemistry - paraffin section on human samples . Clin Exp Immunol (1995) ncbi
BioLegend
mouse recombinant (QA16A02)
  • flow cytometry; mouse; 1:25; loading ...
BioLegend granzyme B antibody (Biolegend, 372206) was used in flow cytometry on mouse samples at 1:25. Nat Commun (2022) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 6d, s4a
BioLegend granzyme B antibody (Biolegend, GB11) was used in flow cytometry on mouse samples (fig 6d, s4a). Front Cell Infect Microbiol (2022) ncbi
mouse recombinant (QA16A02)
  • flow cytometry; mouse; 1:50; loading ...; fig 6h
BioLegend granzyme B antibody (Biolgend, 372206) was used in flow cytometry on mouse samples at 1:50 (fig 6h). Nat Commun (2022) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 3f
BioLegend granzyme B antibody (Biolegend, GB11) was used in flow cytometry on mouse samples (fig 3f). Theranostics (2022) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig s1a, s4f
BioLegend granzyme B antibody (BioLegend, 515408) was used in flow cytometry on mouse samples (fig s1a, s4f). Sci Adv (2022) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 3f
BioLegend granzyme B antibody (Biolegend, GB11) was used in flow cytometry on mouse samples (fig 3f). Oncoimmunology (2022) ncbi
mouse recombinant (QA16A02)
  • flow cytometry; mouse; fig s6d
BioLegend granzyme B antibody (Biolegend, QA16A02) was used in flow cytometry on mouse samples (fig s6d). Nat Commun (2022) ncbi
mouse recombinant (QA16A02)
  • flow cytometry; mouse; 1:50; loading ...; fig 6i, s8
BioLegend granzyme B antibody (Biolegend, 372213) was used in flow cytometry on mouse samples at 1:50 (fig 6i, s8). Nat Commun (2022) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 2m
BioLegend granzyme B antibody (Biolegend, 515403) was used in flow cytometry on mouse samples (fig 2m). J Immunother Cancer (2022) ncbi
rat recombinant (QA18A28)
  • flow cytometry; mouse; loading ...; fig 1e, s2e
BioLegend granzyme B antibody (BioLegend, 396412) was used in flow cytometry on mouse samples (fig 1e, s2e). J Immunother Cancer (2022) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:50; fig 4c
BioLegend granzyme B antibody (BioLegend, 515403) was used in flow cytometry on mouse samples at 1:50 (fig 4c). J Biol Chem (2022) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig s10
BioLegend granzyme B antibody (BioLegend, GB11) was used in flow cytometry on human samples (fig s10). Oncoimmunology (2022) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:100; fig 3f, 3g, s7c
BioLegend granzyme B antibody (Biolegend, 515408) was used in flow cytometry on mouse samples at 1:100 (fig 3f, 3g, s7c). Nat Nanotechnol (2022) ncbi
mouse recombinant (QA16A02)
  • flow cytometry; mouse; 1:100; fig 4f, 4g
BioLegend granzyme B antibody (Biolegend, 372203) was used in flow cytometry on mouse samples at 1:100 (fig 4f, 4g). Nat Nanotechnol (2022) ncbi
mouse recombinant (QA16A02)
  • flow cytometry; mouse; 1:100; fig 1d
BioLegend granzyme B antibody (BioLegend, QA16A02) was used in flow cytometry on mouse samples at 1:100 (fig 1d). J Immunother Cancer (2021) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 5b
BioLegend granzyme B antibody (BioLegend, GB11) was used in flow cytometry on mouse samples (fig 5b). Commun Biol (2021) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig s4c
BioLegend granzyme B antibody (Biolegend, 515408) was used in flow cytometry on mouse samples (fig s4c). J Immunother Cancer (2021) ncbi
mouse recombinant (QA16A02)
  • flow cytometry; mouse; loading ...; fig s3b
BioLegend granzyme B antibody (Biolegend, 372213) was used in flow cytometry on mouse samples (fig s3b). J Immunother Cancer (2021) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:100; loading ...; fig s4b
BioLegend granzyme B antibody (BioLegend, 515405) was used in flow cytometry on mouse samples at 1:100 (fig s4b). iScience (2021) ncbi
mouse recombinant (QA16A02)
  • flow cytometry; mouse; 1:100; fig 4e
BioLegend granzyme B antibody (BioLegend, 372204) was used in flow cytometry on mouse samples at 1:100 (fig 4e). Nat Commun (2021) ncbi
mouse recombinant (QA16A02)
  • flow cytometry; mouse; loading ...; fig s4c
BioLegend granzyme B antibody (Biolegend, 372208) was used in flow cytometry on mouse samples (fig s4c). JCI Insight (2021) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:200; loading ...; fig 3d
BioLegend granzyme B antibody (BioLegend, 515405) was used in flow cytometry on mouse samples at 1:200 (fig 3d). Proc Natl Acad Sci U S A (2021) ncbi
mouse recombinant (QA16A02)
  • flow cytometry; mouse; 1:50; fig s16a
BioLegend granzyme B antibody (BioLegend, QA16A02) was used in flow cytometry on mouse samples at 1:50 (fig s16a). Sci Transl Med (2021) ncbi
rat recombinant (QA18A28)
  • flow cytometry; mouse; loading ...; fig 8a
BioLegend granzyme B antibody (BioLegend, 396413) was used in flow cytometry on mouse samples (fig 8a). Neoplasia (2021) ncbi
mouse recombinant (QA16A02)
  • flow cytometry; human; fig 2f
  • flow cytometry; mouse; fig 6f
BioLegend granzyme B antibody (Biolegend, 372204) was used in flow cytometry on human samples (fig 2f) and in flow cytometry on mouse samples (fig 6f). Sci Rep (2021) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 3e
BioLegend granzyme B antibody (Biolegend, 515406) was used in flow cytometry on human samples (fig 3e). Cell (2020) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:100; loading ...; fig ev2c
BioLegend granzyme B antibody (BioLegend, 515408) was used in flow cytometry on mouse samples at 1:100 (fig ev2c). EMBO Mol Med (2020) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 5f, 5g
BioLegend granzyme B antibody (Biolegend, GB11) was used in flow cytometry on mouse samples (fig 5f, 5g). Science (2020) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:100; loading ...; fig 8d
BioLegend granzyme B antibody (BioLegend, 515406) was used in flow cytometry on mouse samples at 1:100 (fig 8d). Nat Commun (2020) ncbi
mouse recombinant (QA16A02)
  • flow cytometry; mouse; fig 3h
BioLegend granzyme B antibody (Biolegend, QA16A02) was used in flow cytometry on mouse samples (fig 3h). Nature (2019) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 2d, 2l
BioLegend granzyme B antibody (BioLegend, GB11) was used in flow cytometry on mouse samples (fig 2d, 2l). Science (2019) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig s5a
BioLegend granzyme B antibody (Biolegend, 515407) was used in flow cytometry on mouse samples (fig s5a). Cell (2019) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 10b
BioLegend granzyme B antibody (Biolegend, 515403) was used in flow cytometry on human samples (fig 10b). Cell Mol Gastroenterol Hepatol (2020) ncbi
mouse recombinant (QA16A02)
  • flow cytometry; mouse; loading ...; fig 5c
BioLegend granzyme B antibody (Biolegend, 372208) was used in flow cytometry on mouse samples (fig 5c). Cell (2019) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:50; fig 4c, 6j
BioLegend granzyme B antibody (Biolegend, 515403) was used in flow cytometry on mouse samples at 1:50 (fig 4c, 6j). Nat Commun (2019) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 3a
BioLegend granzyme B antibody (BioLegend, GB11) was used in flow cytometry on human samples (fig 3a). J Immunol (2019) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 2a
BioLegend granzyme B antibody (BioLegend, GB11) was used in flow cytometry on human samples (fig 2a). J Immunol (2019) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:100; loading ...; fig s2b
BioLegend granzyme B antibody (Biolegend, 515403) was used in flow cytometry on mouse samples at 1:100 (fig s2b). Nat Commun (2019) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; 1:100; loading ...; fig 3h
BioLegend granzyme B antibody (Biolegend, GB11) was used in flow cytometry on human samples at 1:100 (fig 3h). elife (2019) ncbi
mouse monoclonal (M3304B06)
  • western blot; human; 1:500; loading ...; fig 3s1b
BioLegend granzyme B antibody (Biolegend, M3304B06) was used in western blot on human samples at 1:500 (fig 3s1b). elife (2019) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend granzyme B antibody (BioLegend, GB11) was used in flow cytometry on mouse samples (fig 3a). Front Immunol (2018) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig s1d
BioLegend granzyme B antibody (Biolegend, GB11) was used in flow cytometry on human samples (fig s1d). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 3f
BioLegend granzyme B antibody (Biolegend, 515403) was used in flow cytometry on mouse samples (fig 3f). Cell Rep (2018) ncbi
mouse recombinant (QA16A02)
  • flow cytometry; mouse; loading ...; fig 3m
BioLegend granzyme B antibody (Biolegend, 372204) was used in flow cytometry on mouse samples (fig 3m). Cancer Res (2018) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig s6a
BioLegend granzyme B antibody (BioLegend, GB11) was used in flow cytometry on human samples (fig s6a). Sci Immunol (2018) ncbi
mouse recombinant (QA16A02)
  • flow cytometry; mouse; loading ...; fig 5c
BioLegend granzyme B antibody (BioLegend, QA16A02) was used in flow cytometry on mouse samples (fig 5c). Cell Immunol (2018) ncbi
mouse recombinant (QA16A02)
  • flow cytometry; human; loading ...; fig 6c
BioLegend granzyme B antibody (BioLegend, QA16A02) was used in flow cytometry on human samples (fig 6c). Int J Infect Dis (2018) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig s2b
BioLegend granzyme B antibody (BioLegend, 515408) was used in flow cytometry on mouse samples (fig s2b). Cell (2018) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig s10g
BioLegend granzyme B antibody (BioLegend, 515403) was used in flow cytometry on mouse samples (fig s10g). Nature (2018) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:200; loading ...; fig 8b
BioLegend granzyme B antibody (Biolegend, 515403) was used in flow cytometry on mouse samples at 1:200 (fig 8b). Nat Cell Biol (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...
In order to evaluate mouse models of hepacivirus infection, BioLegend granzyme B antibody (Biolegend, GB11) was used in flow cytometry on mouse samples . Science (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 4c
BioLegend granzyme B antibody (BioLegend, GB11) was used in flow cytometry on human samples (fig 4c). Oncotarget (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 6a
BioLegend granzyme B antibody (BioLegend, GB11) was used in flow cytometry on human samples (fig 6a). J Exp Med (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig s6d
In order to demonstrate that neonatal CD8 positive T cells have a specific genetic program biased toward the innate immune response, BioLegend granzyme B antibody (Biolegend, GB11) was used in flow cytometry on human samples (fig s6d). Cell Rep (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 4a
In order to functionally characterize herpes simplex virus-specific CD8 positive T cells, BioLegend granzyme B antibody (BioLegend, GB11) was used in flow cytometry on human samples (fig 4a). J Virol (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 1e
In order to investigate the role of Eomes in the retention of liver natural killer cells, BioLegend granzyme B antibody (BioLegend, GB11) was used in flow cytometry on human samples (fig 1e). J Immunol (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:400; loading ...; fig 3a
In order to test how inhibiting autophagy impacts antitumor immune responses in immune-competent mouse models of melanoma and mammary cancer, BioLegend granzyme B antibody (BioLegend, GB11) was used in flow cytometry on mouse samples at 1:400 (fig 3a). J Clin Invest (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 3b
In order to study T cell migration in inflammatory demyelinating lesions confined to optic nerves and spinal cord, BioLegend granzyme B antibody (BioLegend, GB11) was used in flow cytometry on mouse samples (fig 3b). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 5
BioLegend granzyme B antibody (Biolegend, GB11) was used in flow cytometry on human samples (fig 5). PLoS Pathog (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:200; loading ...; tbl s2
In order to identify and characterize follicular cytotoxic T cells, BioLegend granzyme B antibody (Biolegend, GB11) was used in flow cytometry on mouse samples at 1:200 (tbl s2). Nat Immunol (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 1
BioLegend granzyme B antibody (Biolegend, GB11) was used in flow cytometry on human samples (fig 1). J Immunol (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig s1
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend granzyme B antibody (biolegend, GB11) was used in flow cytometry on human samples (fig s1). J Immunol (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 1
In order to assess arming of MAIT cell cytolytic antimicrobial activity and induction by IL-7 and faulty in HIV-1 infection, BioLegend granzyme B antibody (Biolegend, GB11) was used in flow cytometry on human samples (fig 1). PLoS Pathog (2015) ncbi
mouse monoclonal (GB11)
  • immunocytochemistry; human; fig 2
In order to investigate the role of VAMP8 in exocytosis, BioLegend granzyme B antibody (BioLegend, GB11) was used in immunocytochemistry on human samples (fig 2). J Cell Biol (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 1
BioLegend granzyme B antibody (BioLegend, GB11) was used in flow cytometry on mouse samples (fig 1). J Immunol (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse
In order to report that AMPK regulates protein phosphatase activity to control the of survival and function of CD8+ T cells, thus regulating immune surveillance of tumors, BioLegend granzyme B antibody (Biolegend, GB11) was used in flow cytometry on mouse samples . Oncotarget (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 7
  • flow cytometry; human; fig 4
BioLegend granzyme B antibody (Biolegend, GB11) was used in flow cytometry on mouse samples (fig 7) and in flow cytometry on human samples (fig 4). J Immunol (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 4
BioLegend granzyme B antibody (BioLegend, GB11) was used in flow cytometry on human samples (fig 4). J Virol (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; 5,000 ug/ml; fig 3
BioLegend granzyme B antibody (BioLegend, GB11) was used in flow cytometry on human samples at 5,000 ug/ml (fig 3). J Surg Res (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 6
BioLegend granzyme B antibody (BioLegend, GB11) was used in flow cytometry on mouse samples (fig 6). Am J Pathol (2014) ncbi
mouse monoclonal (GB11)
BioLegend granzyme B antibody (BioLegend, 515403) was used . Cancer Res (2014) ncbi
Abcam
mouse monoclonal (GZMB/2403)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s16c
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig s1e
Abcam granzyme B antibody (Abcam, ab237847) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s16c) and in immunohistochemistry - paraffin section on human samples at 1:100 (fig s1e). Sci Transl Med (2021) ncbi
domestic rabbit monoclonal (EPR8260)
  • immunohistochemistry; human; 1:300; loading ...; fig 2b
Abcam granzyme B antibody (Abcam, ab134933) was used in immunohistochemistry on human samples at 1:300 (fig 2b). Cancer Immunol Immunother (2020) ncbi
domestic rabbit monoclonal (EPR8260)
  • immunohistochemistry; human; loading ...; fig 9a
In order to investigate the tumor microenvironment in tertiary lymphoid organs of prostate cancer patients, Abcam granzyme B antibody (Abcam, EPR8260) was used in immunohistochemistry on human samples (fig 9a). Front Immunol (2017) ncbi
Santa Cruz Biotechnology
mouse monoclonal (2C5)
  • western blot; mouse; 1:1000; loading ...; fig 8g
Santa Cruz Biotechnology granzyme B antibody (Santa Cruz Biotechnology, sc-8022) was used in western blot on mouse samples at 1:1000 (fig 8g). Nat Commun (2022) ncbi
mouse monoclonal (2C5)
  • immunohistochemistry - frozen section; human; 1:50; fig 2
In order to learn the possible role of incipient renal fibrosis by variable expression of neural cell adhesion molecule isoforms in renal tissue, Santa Cruz Biotechnology granzyme B antibody (Santa Cruz Biotechnology, sc-8022) was used in immunohistochemistry - frozen section on human samples at 1:50 (fig 2). PLoS ONE (2015) ncbi
Bio-Rad
mouse monoclonal (GB11)
  • flow cytometry; human
In order to study NK function in solid tumors, Bio-Rad granzyme B antibody (AbD Serotec, GB11) was used in flow cytometry on human samples . Int J Cancer (2014) ncbi
Dako
mouse monoclonal (GrB-7)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 3
In order to characterize cases of recurrent panniculitis in children with lipoatrophy, Dako granzyme B antibody (DAKO, GRB-7) was used in immunohistochemistry - paraffin section on human samples (tbl 3). J Eur Acad Dermatol Venereol (2017) ncbi
mouse monoclonal (GrB-7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 5f
Dako granzyme B antibody (Dako, GrB-7) was used in immunohistochemistry - paraffin section on human samples (fig 5f). J Immunol (2016) ncbi
mouse monoclonal (GrB-7)
  • immunohistochemistry; mouse; fig 6a
In order to utilize humanized major histocompatibility class I- and class II-deficient NOG mice to assess the antitumor effect of an anti-programmed death-1 antibody, Dako granzyme B antibody (DAKO, GrB-7) was used in immunohistochemistry on mouse samples (fig 6a). Clin Cancer Res (2017) ncbi
mouse monoclonal (GrB-7)
  • immunohistochemistry; human; 1:10
In order to describe the gluteal lesions of a patient with pagetoid reticulosis, Dako granzyme B antibody (Dako, GrB7) was used in immunohistochemistry on human samples at 1:10. J Cutan Pathol (2015) ncbi
mouse monoclonal (GrB-7)
  • immunohistochemistry - paraffin section; human
Dako granzyme B antibody (Dako, GrB-7) was used in immunohistochemistry - paraffin section on human samples . J Cutan Pathol (2015) ncbi
mouse monoclonal (GrB-7)
  • immunohistochemistry; human; 1:40
Dako granzyme B antibody (Dako, GrB-7) was used in immunohistochemistry on human samples at 1:40. J Cutan Pathol (2015) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • flow cytometry; mouse
Cell Signaling Technology granzyme B antibody (Cell Signaling Technology, 4275) was used in flow cytometry on mouse samples . EMBO Mol Med (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:2000; loading ...; fig 3d
Cell Signaling Technology granzyme B antibody (Cell Signaling Technology, 4275) was used in western blot on mouse samples at 1:2000 (fig 3d). Nat Commun (2019) ncbi
domestic rabbit monoclonal (D6E9W)
  • immunohistochemistry; mouse; loading ...; fig 2v
Cell Signaling Technology granzyme B antibody (Cell Signaling, D6E9W) was used in immunohistochemistry on mouse samples (fig 2v). J Immunol (2019) ncbi
domestic rabbit polyclonal
  • other; human; loading ...; fig 4c
Cell Signaling Technology granzyme B antibody (Cell Signaling, 4275) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s11a
In order to quantify changes in cytoplasmic and mitochondrial interactomes in response to apoptosis initiation as a function of caspase activity, Cell Signaling Technology granzyme B antibody (Cell Signaling, 4275) was used in western blot on human samples (fig s11a). Mol Syst Biol (2017) ncbi
BD Biosciences
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 3i
BD Biosciences granzyme B antibody (BD, 560211) was used in flow cytometry on human samples (fig 3i). Nat Commun (2022) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 4c
  • flow cytometry; human; loading ...; fig 2c
BD Biosciences granzyme B antibody (BD, 560212) was used in flow cytometry on mouse samples (fig 4c) and in flow cytometry on human samples (fig 2c). Sci Adv (2022) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; 1:100; loading ...; fig s1c
BD Biosciences granzyme B antibody (BD Biosciences, GB11) was used in flow cytometry on human samples at 1:100 (fig s1c). Nature (2021) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 7a-7b
BD Biosciences granzyme B antibody (BD Biosciences, 560212) was used in flow cytometry on human samples (fig 7a-7b). elife (2020) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 14a
BD Biosciences granzyme B antibody (BD Biosciences, 560211) was used in flow cytometry on human samples (fig 14a). Hum Vaccin Immunother (2020) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 3a, 6g
BD Biosciences granzyme B antibody (BD Biosciences, 562462) was used in flow cytometry on mouse samples (fig 3a, 6g). Cell Rep (2019) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 6c
BD Biosciences granzyme B antibody (BD Pharmingen, 561142) was used in flow cytometry on human samples (fig 6c). Sci Rep (2019) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig s6g
BD Biosciences granzyme B antibody (BD Biosciences, 560213) was used in flow cytometry on mouse samples (fig s6g). Cell (2019) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences granzyme B antibody (BD Biosciences, GB11) was used in flow cytometry on human samples (fig 1b). Eur J Immunol (2019) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 2d
BD Biosciences granzyme B antibody (BD Biosciences, 560213) was used in flow cytometry on human samples (fig 2d). Cell Rep (2018) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig s3a
BD Biosciences granzyme B antibody (BD Biosciences, GB11) was used in flow cytometry on human samples (fig s3a). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig s6
BD Biosciences granzyme B antibody (BD, GB11) was used in flow cytometry on human samples (fig s6). J Clin Invest (2018) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 3d
BD Biosciences granzyme B antibody (BD Biosciences, GB11) was used in flow cytometry on human samples (fig 3d). Clin Exp Immunol (2018) ncbi
mouse monoclonal (GB11)
  • flow cytometry; African green monkey; loading ...; fig s5a
BD Biosciences granzyme B antibody (BD Biosciences, 561142) was used in flow cytometry on African green monkey samples (fig s5a). J Clin Invest (2018) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 2g
BD Biosciences granzyme B antibody (BD Biosciences, GB11) was used in flow cytometry on human samples (fig 2g). J Clin Invest (2018) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 2b
BD Biosciences granzyme B antibody (BD Biosciences, GB11) was used in flow cytometry on mouse samples (fig 2b). J Immunol (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 3b
In order to characterize fetal natural killer cells, BD Biosciences granzyme B antibody (BD Biosciences, GB11) was used in flow cytometry on human samples (fig 3b). JCI Insight (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 5c
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BD Biosciences granzyme B antibody (BD Bioscience, GB11) was used in flow cytometry on human samples (fig 5c). Sci Rep (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; rhesus macaque; loading ...; fig 2b
In order to examine the kinetics of SIV-specific CD8+ T cell cytolytic factor expression in peripheral blood, lymph node, spleen, and gut mucosa from early acute infection through chronic infection, BD Biosciences granzyme B antibody (BD Biosciences, GB11) was used in flow cytometry on rhesus macaque samples (fig 2b). PLoS Pathog (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 5a
BD Biosciences granzyme B antibody (BD Biosciences, GB11) was used in flow cytometry on mouse samples (fig 5a). Cell (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 1e
In order to characterize gammadelta T cell subsets from healthy humans, BD Biosciences granzyme B antibody (BD, GB11) was used in flow cytometry on human samples (fig 1e). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 3a
In order to characterize CD8 positive alpha beta gamma delta T cells, BD Biosciences granzyme B antibody (BD Biosciences, GB11) was used in flow cytometry on human samples (fig 3a). J Immunol (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig s4b
BD Biosciences granzyme B antibody (BD Biosciences, GB11) was used in flow cytometry on human samples (fig s4b). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 3
In order to assess receptor for hyaluronic acid-mediated motility specific dendritic cell responses, BD Biosciences granzyme B antibody (BD Biosciences, 560211) was used in flow cytometry on human samples (fig 3). Oncotarget (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences granzyme B antibody (BD Biosciences, GB11) was used in flow cytometry on human samples (fig 2a). Sci Rep (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences granzyme B antibody (Becton-Dickinson, GB11) was used in flow cytometry on human samples (fig s1). J Immunol (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 3
BD Biosciences granzyme B antibody (BD Biosciences, 561998) was used in flow cytometry on human samples (fig 3). Oncoimmunology (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 1
BD Biosciences granzyme B antibody (BD Pharmigen, 560212) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 3e
BD Biosciences granzyme B antibody (BD, GB11) was used in flow cytometry on human samples (fig 3e). J Clin Invest (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; African green monkey; loading ...; fig 1g
In order to discuss the use of flow cytometry to examine common marmosets, BD Biosciences granzyme B antibody (BD, GB11) was used in flow cytometry on African green monkey samples (fig 1g). J Med Primatol (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 3
In order to study chronic hepatitis C virus infections and the functional dichotomy of V-delta2 gamma-delta T cells and their role in cytotoxicity and not IFN-gamma production, BD Biosciences granzyme B antibody (BD PharMingen, GB11) was used in flow cytometry on human samples (fig 3). Sci Rep (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 3c
In order to assess the impact of neoantigen intratumor heterogeneity on antitumor immunity, BD Biosciences granzyme B antibody (BD Biosciences, GB11) was used in flow cytometry on human samples (fig 3c). Science (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 1
In order to elucidate mechanisms that regulate T cell glycolytic metabolism, BD Biosciences granzyme B antibody (BD Biosciences, GB11) was used in flow cytometry on human samples (fig 1). Nat Immunol (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig s7
In order to study the use of bispecific T cell engager, BD Biosciences granzyme B antibody (BD Biosciences, GB11) was used in flow cytometry on human samples (fig s7). PLoS ONE (2015) ncbi
mouse monoclonal (2C5/F5)
  • flow cytometry; mouse; loading ...; fig 4c
In order to investigate the role of TIGIT in the immune response, BD Biosciences granzyme B antibody (BD Pharmingen, 2C5/F5) was used in flow cytometry on mouse samples (fig 4c). J Clin Invest (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 1
In order to assess arming of MAIT cell cytolytic antimicrobial activity and induction by IL-7 and faulty in HIV-1 infection, BD Biosciences granzyme B antibody (BD Biosciences, GB11) was used in flow cytometry on human samples (fig 1). PLoS Pathog (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 1a
In order to examine the effects of immunosuppressive agents on Polyomavirus BKV-specific T cells, BD Biosciences granzyme B antibody (BD Bioscience, GB11) was used in flow cytometry on human samples (fig 1a). Kidney Int (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human
BD Biosciences granzyme B antibody (BD, GB11) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human
In order to examine the phenotype and function of peripheral gammadelta T cells in patients with chronic hepatitis B during pegylated-interferon-alpha treatment, BD Biosciences granzyme B antibody (BD, GB11) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (2C5/F5)
  • western blot; human
BD Biosciences granzyme B antibody (BD Biosciences, 2C5/F5) was used in western blot on human samples . Mol Immunol (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; tbl s2
In order to examine the early impact of viral replicative capacity on HIV-1 immunopathogenesis, BD Biosciences granzyme B antibody (BD Biosciences, GB11) was used in flow cytometry on human samples (tbl s2). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 3
BD Biosciences granzyme B antibody (BD Biosciences, GB11) was used in flow cytometry on human samples (fig 3). J Immunol (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; tbl s5
In order to investigate when Vgamma9Vdelta2 T cells develop, BD Biosciences granzyme B antibody (BD Bioscience, GB11) was used in flow cytometry on human samples (tbl s5). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human
BD Biosciences granzyme B antibody (BD, GB11) was used in flow cytometry on human samples . Clin Cancer Res (2014) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human
In order to examine the effect of lytic EBV antigen-specific CD8+ T cells on EBV infection in humanized mice, BD Biosciences granzyme B antibody (BD Pharmigen, GB11) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human
BD Biosciences granzyme B antibody (BD Bioscience, GB11) was used in flow cytometry on human samples . Med Microbiol Immunol (2014) ncbi
Leica Biosystems
monoclonal (11F1)
  • immunohistochemistry; human; 1:100; loading ...
Leica Biosystems granzyme B antibody (Novocastra, 11F1) was used in immunohistochemistry on human samples at 1:100. Ann Hematol (2021) ncbi
monoclonal (11F1)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1a
Leica Biosystems granzyme B antibody (Leica, PA0299) was used in immunohistochemistry - paraffin section on human samples (fig 1a). Cancer Res (2021) ncbi
mouse monoclonal (11F1)
  • immunohistochemistry - paraffin section; human; 1:20; fig s3
Leica Biosystems granzyme B antibody (Novocastra, NCL-Gran-B) was used in immunohistochemistry - paraffin section on human samples at 1:20 (fig s3). Oncoimmunology (2017) ncbi
monoclonal (11F1)
  • immunohistochemistry; human; fig 3a
Leica Biosystems granzyme B antibody (Leica Biosysytems, PA0299) was used in immunohistochemistry on human samples (fig 3a). PLoS ONE (2017) ncbi
Articles Reviewed
  1. Yang P, Qin H, Li Y, Xiao A, Zheng E, Zeng H, et al. CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis. Nat Commun. 2022;13:5782 pubmed publisher
  2. Hou X, Shi Y, Kang X, Rousu Z, Li D, Wang M, et al. Echinococcus granulosus: The establishment of the metacestode in the liver is associated with control of the CD4+ T-cell-mediated immune response in patients with cystic echinococcosis and a mouse model. Front Cell Infect Microbiol. 2022;12:983119 pubmed publisher
  3. Xie F, Zhou X, Su P, Li H, Tu Y, Du J, et al. Breast cancer cell-derived extracellular vesicles promote CD8+ T cell exhaustion via TGF-β type II receptor signaling. Nat Commun. 2022;13:4461 pubmed publisher
  4. Wu B, Song M, Dong Q, Xiang G, Li J, Ma X, et al. UBR5 promotes tumor immune evasion through enhancing IFN-γ-induced PDL1 transcription in triple negative breast cancer. Theranostics. 2022;12:5086-5102 pubmed publisher
  5. Lei X, Lin H, Wang J, Ou Z, Ruan Y, Sadagopan A, et al. Mitochondrial fission induces immunoescape in solid tumors through decreasing MHC-I surface expression. Nat Commun. 2022;13:3882 pubmed publisher
  6. Chen P, Katsuyama E, Satyam A, Li H, Rubio J, Jung S, et al. CD38 reduces mitochondrial fitness and cytotoxic T cell response against viral infection in lupus patients by suppressing mitophagy. Sci Adv. 2022;8:eabo4271 pubmed publisher
  7. Garnier L, Pick R, Montorfani J, Sun M, Brighouse D, Liaudet N, et al. IFN-γ-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis. Sci Adv. 2022;8:eabl5162 pubmed publisher
  8. Pan C, Wu Q, Wang S, Mei Z, Zhang L, Gao X, et al. Combination with Toll-like receptor 4 (TLR4) agonist reverses GITR agonism mediated M2 polarization of macrophage in Hepatocellular carcinoma. Oncoimmunology. 2022;11:2073010 pubmed publisher
  9. Piao W, Li L, Saxena V, Iyyathurai J, Lakhan R, Zhang Y, et al. PD-L1 signaling selectively regulates T cell lymphatic transendothelial migration. Nat Commun. 2022;13:2176 pubmed publisher
  10. Xiong W, Gao X, Zhang T, Jiang B, Hu M, Bu X, et al. USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy. Nat Commun. 2022;13:1700 pubmed publisher
  11. van Vloten J, Matuszewska K, Minow M, Minott J, Santry L, Pereira M, et al. Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer. J Immunother Cancer. 2022;10: pubmed publisher
  12. Tang T, Huang X, Zhang G, Lu M, Hong Z, Wang M, et al. Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axis. J Immunother Cancer. 2022;10: pubmed publisher
  13. Cha J, Chan L, Wang Y, Chu Y, Wang C, Lee H, et al. Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer. J Biol Chem. 2022;298:101817 pubmed publisher
  14. Kono M, Komatsuda H, Yamaki H, Kumai T, Hayashi R, Wakisaka R, et al. Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma. Oncoimmunology. 2022;11:2021619 pubmed publisher
  15. Liu Y, Wang L, Song Q, Ali M, Crowe W, Kucera G, et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Nat Nanotechnol. 2022;17:206-216 pubmed publisher
  16. Liu H, Pedros C, Kong K, Canonigo Balancio A, Xue W, Altman A. Leveraging the Treg-intrinsic CTLA4-PKCη signaling pathway for cancer immunotherapy. J Immunother Cancer. 2021;9: pubmed publisher
  17. Susukida T, Kuwahara S, Song B, Kazaoka A, Aoki S, Ito K. Regulation of the immune tolerance system determines the susceptibility to HLA-mediated abacavir-induced skin toxicity. Commun Biol. 2021;4:1137 pubmed publisher
  18. Lu C, Liu Z, Klement J, Yang D, Merting A, Poschel D, et al. WDR5-H3K4me3 epigenetic axis regulates OPN expression to compensate PD-L1 function to promote pancreatic cancer immune escape. J Immunother Cancer. 2021;9: pubmed publisher
  19. Oberhardt V, Luxenburger H, Kemming J, Schulien I, Ciminski K, Giese S, et al. Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine. Nature. 2021;597:268-273 pubmed publisher
  20. Hutton C, Heider F, Blanco Gómez A, Banyard A, Kononov A, Zhang X, et al. Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity. Cancer Cell. 2021;: pubmed publisher
  21. James O, Vandereyken M, Marchingo J, Singh F, Bray S, Wilson J, et al. IL-15 and PIM kinases direct the metabolic programming of intestinal intraepithelial lymphocytes. Nat Commun. 2021;12:4290 pubmed publisher
  22. Lauret Marie Joseph E, Kirilovsky A, Lecoester B, El Sissy C, Boullerot L, Rangan L, et al. Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy. J Immunother Cancer. 2021;9: pubmed publisher
  23. Souza C, Ketelut Carneiro N, Milanezi C, Faccioli L, Gardinassi L, Silva J. NLRC4 inhibits NLRP3 inflammasome and abrogates effective antifungal CD8+ T cell responses. iScience. 2021;24:102548 pubmed publisher
  24. Uyanik B, Goloudina A, Akbarali A, Grigorash B, Petukhov A, Singhal S, et al. Inhibition of the DNA damage response phosphatase PPM1D reprograms neutrophils to enhance anti-tumor immune responses. Nat Commun. 2021;12:3622 pubmed publisher
  25. Amoozgar Z, Kloepper J, Ren J, Tay R, Kazer S, Kiner E, et al. Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas. Nat Commun. 2021;12:2582 pubmed publisher
  26. Bonilla W, Kirchhammer N, Marx A, Kallert S, Krzyzaniak M, Lu M, et al. Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack. Cell Rep Med. 2021;2:100209 pubmed publisher
  27. Brune M, Stussi G, Lundberg P, Vela V, Heim D, Manz M, et al. Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort. Ann Hematol. 2021;100:1169-1179 pubmed publisher
  28. Xiao Y, Shu L, Wu X, Liu Y, Cheong L, Liao B, et al. Fatty acid binding protein 4 promotes autoimmune diabetes by recruitment and activation of pancreatic islet macrophages. JCI Insight. 2021;6: pubmed publisher
  29. Lu M, Dravid P, Zhang Y, Trivedi S, Li A, Harder O, et al. A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  30. Mondal T, Shivange G, Tihagam R, Lyerly E, Battista M, Talwar D, et al. Unexpected PD-L1 immune evasion mechanism in TNBC, ovarian, and other solid tumors by DR5 agonist antibodies. EMBO Mol Med. 2021;13:e12716 pubmed publisher
  31. Li Y, Sun Y, Kulke M, Hechler T, Van der Jeught K, Dong T, et al. Targeted immunotherapy for HER2-low breast cancer with 17p loss. Sci Transl Med. 2021;13: pubmed publisher
  32. Davenport M, Echols J, Silva A, Anderson J, Owens P, Yates C, et al. miR-31 displays subtype specificity in lung cancer. Cancer Res. 2021;: pubmed publisher
  33. Wang F, Ye W, Wang S, He Y, Zhong H, Wang Y, et al. Discovery of a new inhibitor targeting PD-L1 for cancer immunotherapy. Neoplasia. 2021;23:281-293 pubmed publisher
  34. Xu K, Yin N, Peng M, Stamatiades E, Shyu A, Li P, et al. Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity. Science. 2021;371:405-410 pubmed publisher
  35. Wang Y, Mohseni M, Grauel A, Diez J, Guan W, Liang S, et al. SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms. Sci Rep. 2021;11:1399 pubmed publisher
  36. Lafouresse F, Jugele R, Müller S, Doineau M, Duplan Eche V, Espinosa E, et al. Stochastic asymmetric repartition of lytic machinery in dividing CD8+ T cells generates heterogeneous killing behavior. elife. 2021;10: pubmed publisher
  37. Bhattacharya P, Ellegård R, Khalid M, Svanberg C, Govender M, Keita A, et al. Complement opsonization of HIV affects primary infection of human colorectal mucosa and subsequent activation of T cells. elife. 2020;9: pubmed publisher
  38. Piersma S, Poursine Laurent J, Yang L, Barber G, Parikh B, Yokoyama W. Virus infection is controlled by hematopoietic and stromal cell sensing of murine cytomegalovirus through STING. elife. 2020;9: pubmed publisher
  39. Mathew D, Giles J, Baxter A, Greenplate A, Wu J, Alanio C, et al. Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions. bioRxiv. 2020;: pubmed publisher
  40. Gunesch J, Dixon A, Ebrahim T, Berrien Elliott M, Tatineni S, Kumar T, et al. CD56 regulates human NK cell cytotoxicity through Pyk2. elife. 2020;9: pubmed publisher
  41. Grifoni A, Weiskopf D, Ramirez S, Mateus J, Dan J, Moderbacher C, et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020;181:1489-1501.e15 pubmed publisher
  42. Fan Z, Tian Y, Chen Z, Liu L, Zhou Q, He J, et al. Blocking interaction between SHP2 and PD-1 denotes a novel opportunity for developing PD-1 inhibitors. EMBO Mol Med. 2020;12:e11571 pubmed publisher
  43. Liu G, Yu Y, Feng F, Zhu P, Zhang H, Zhang D, et al. Human CD8+CD28- T suppressor cells expanded by common gamma chain (γc) cytokines retain steady allospecific suppressive capacity in vivo. BMC Immunol. 2020;21:23 pubmed publisher
  44. Wang J, Li P, Yu Y, Fu Y, Jiang H, Lu M, et al. Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity. Science. 2020;367: pubmed publisher
  45. Terashima Y, Toda E, Itakura M, Otsuji M, Yoshinaga S, Okumura K, et al. Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties. Nat Commun. 2020;11:609 pubmed publisher
  46. Boudewijns S, Bloemendal M, de Haas N, Westdorp H, Bol K, Schreibelt G, et al. Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial. Cancer Immunol Immunother. 2020;69:477-488 pubmed publisher
  47. Wei J, Long L, Zheng W, Dhungana Y, Lim S, Guy C, et al. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy. Nature. 2019;576:471-476 pubmed publisher
  48. Leone R, Zhao L, Englert J, Sun I, Oh M, Sun I, et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science. 2019;366:1013-1021 pubmed publisher
  49. Ma A, Motyka B, Gutfreund K, Shi Y, George R. A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B. Hum Vaccin Immunother. 2020;16:756-778 pubmed publisher
  50. Chen Z, Ji Z, Ngiow S, Manne S, Cai Z, Huang A, et al. TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision. Immunity. 2019;51:840-855.e5 pubmed publisher
  51. Nelson C, Thompson E, Quarnstrom C, Fraser K, Seelig D, Bhela S, et al. Robust Iterative Stimulation with Self-Antigens Overcomes CD8+ T Cell Tolerance to Self- and Tumor Antigens. Cell Rep. 2019;28:3092-3104.e5 pubmed publisher
  52. Wolf Y, Bartok O, Patkar S, Eli G, Cohen S, Litchfield K, et al. UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma. Cell. 2019;179:219-235.e21 pubmed publisher
  53. Di Blasi D, Boldanova T, Mori L, Terracciano L, Heim M, De Libero G. Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma. Cell Mol Gastroenterol Hepatol. 2020;9:195-218 pubmed publisher
  54. Dong M, Wang G, Chow R, Ye L, Zhu L, Dai X, et al. Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells. Cell. 2019;178:1189-1204.e23 pubmed publisher
  55. Benci J, Johnson L, Choa R, Xu Y, Qiu J, Zhou Z, et al. Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade. Cell. 2019;178:933-948.e14 pubmed publisher
  56. Ramaglia V, Sheikh Mohamed S, Legg K, Park C, Rojas O, Zandee S, et al. Multiplexed imaging of immune cells in staged multiple sclerosis lesions by mass cytometry. elife. 2019;8: pubmed publisher
  57. Leclerc M, Voilin E, Gros G, Corgnac S, de Montpreville V, Validire P, et al. Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1. Nat Commun. 2019;10:3345 pubmed publisher
  58. Meckiff B, Ladell K, McLaren J, Ryan G, Leese A, James E, et al. Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells. J Immunol. 2019;203:1276-1287 pubmed publisher
  59. Shokri M, Bozorgmehr M, Ghanavatinejad A, Falak R, Aleahmad M, Kazemnejad S, et al. Human menstrual blood-derived stromal/stem cells modulate functional features of natural killer cells. Sci Rep. 2019;9:10007 pubmed publisher
  60. Kim A, Han C, Driver I, Olow A, Sewell A, Zhang Z, et al. LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody-Induced Tumor Cell Killing by Effector CD8+ T Cells. J Immunol. 2019;203:1076-1087 pubmed publisher
  61. LaFleur M, Nguyen T, Coxe M, Yates K, Trombley J, Weiss S, et al. A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system. Nat Commun. 2019;10:1668 pubmed publisher
  62. Spolski R, West E, Li P, Veenbergen S, Yung S, Kazemian M, et al. IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus. elife. 2019;8: pubmed publisher
  63. Poggio M, Hu T, Pai C, Chu B, BELAIR C, Chang A, et al. Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory. Cell. 2019;177:414-427.e13 pubmed publisher
  64. Cao Y, Trillo Tinoco J, Sierra R, Anadon C, Dai W, Mohamed E, et al. ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression. Nat Commun. 2019;10:1280 pubmed publisher
  65. Remmerswaal E, Hombrink P, Nota B, Pircher H, ten Berge I, van Lier R, et al. Expression of IL-7Rα and KLRG1 defines functionally distinct CD8+ T-cell populations in humans. Eur J Immunol. 2019;49:694-708 pubmed publisher
  66. Mayassi T, Ladell K, Gudjonson H, McLaren J, Shaw D, Tran M, et al. Chronic Inflammation Permanently Reshapes Tissue-Resident Immunity in Celiac Disease. Cell. 2019;176:967-981.e19 pubmed publisher
  67. Sorrelle N, Ganguly D, Dominguez A, Zhang Y, Huang H, Dahal L, et al. Improved Multiplex Immunohistochemistry for Immune Microenvironment Evaluation of Mouse Formalin-Fixed, Paraffin-Embedded Tissues. J Immunol. 2019;202:292-299 pubmed publisher
  68. Muscate F, Stetter N, Schramm C, Schulze zur Wiesch J, Bosurgi L, Jacobs T. HVEM and CD160: Regulators of Immunopathology During Malaria Blood-Stage. Front Immunol. 2018;9:2611 pubmed publisher
  69. Kim C, Hu B, Jadhav R, Jin J, Zhang H, Cavanagh M, et al. Activation of miR-21-Regulated Pathways in Immune Aging Selects against Signatures Characteristic of Memory T Cells. Cell Rep. 2018;25:2148-2162.e5 pubmed publisher
  70. Dias J, Boulouis C, Gorin J, van den Biggelaar R, Lal K, Gibbs A, et al. The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. Proc Natl Acad Sci U S A. 2018;115:E11513-E11522 pubmed publisher
  71. Jensen I, Winborn C, Fosdick M, Shao P, Tremblay M, Shan Q, et al. Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections. PLoS Pathog. 2018;14:e1007405 pubmed publisher
  72. Petrelli A, Mijnheer G, Hoytema van Konijnenburg D, van der Wal M, Giovannone B, Mocholí E, et al. PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation. J Clin Invest. 2018;128:4669-4681 pubmed publisher
  73. Geary C, Krishna C, Lau C, Adams N, Gearty S, Pritykin Y, et al. Non-redundant ISGF3 Components Promote NK Cell Survival in an Auto-regulatory Manner during Viral Infection. Cell Rep. 2018;24:1949-1957.e6 pubmed publisher
  74. Hartana C, Ahlén Bergman E, Broome A, Berglund S, Johansson M, Alamdari F, et al. Tissue-resident memory T cells are epigenetically cytotoxic with signs of exhaustion in human urinary bladder cancer. Clin Exp Immunol. 2018;194:39-53 pubmed publisher
  75. Tan B, Shi X, Zhang J, Qin J, Zhang N, Ren H, et al. Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization. Cancer Res. 2018;78:4929-4942 pubmed publisher
  76. Galperin M, Farenc C, Mukhopadhyay M, Jayasinghe D, Decroos A, Benati D, et al. CD4+ T cell-mediated HLA class II cross-restriction in HIV controllers. Sci Immunol. 2018;3: pubmed publisher
  77. Provine N, Binder B, FitzPatrick M, Schuch A, Garner L, Williamson K, et al. Unique and Common Features of Innate-Like Human Vδ2+ γδT Cells and Mucosal-Associated Invariant T Cells. Front Immunol. 2018;9:756 pubmed publisher
  78. Ferrando Martinez S, Moysi E, Pegu A, Andrews S, Nganou Makamdop K, Ambrozak D, et al. Accumulation of follicular CD8+ T cells in pathogenic SIV infection. J Clin Invest. 2018;128:2089-2103 pubmed publisher
  79. Harker J, Wong K, Dallari S, Bao P, Dolgoter A, Jo Y, et al. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection. J Virol. 2018;92: pubmed publisher
  80. Xiao F, Ai G, Yan W, Wan X, Luo X, Ning Q. Intrahepatic recruitment of cytotoxic NK cells contributes to autoimmune hepatitis progression. Cell Immunol. 2018;327:13-20 pubmed publisher
  81. Li M, Zhang W, Liu J, Li M, Zhang Y, Xiong Y, et al. Dynamic changes in the immunological characteristics of T lymphocytes in surviving patients with severe fever with thrombocytopenia syndrome (SFTS). Int J Infect Dis. 2018;70:72-80 pubmed publisher
  82. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  83. Li N, van Unen V, Höllt T, Thompson A, van Bergen J, Pezzotti N, et al. Mass cytometry reveals innate lymphoid cell differentiation pathways in the human fetal intestine. J Exp Med. 2018;215:1383-1396 pubmed publisher
  84. Böttcher J, Bonavita E, Chakravarty P, Blees H, Cabeza Cabrerizo M, Sammicheli S, et al. NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control. Cell. 2018;172:1022-1037.e14 pubmed publisher
  85. Pizzolla A, Nguyen T, Sant S, Jaffar J, Loudovaris T, Mannering S, et al. Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles. J Clin Invest. 2018;128:721-733 pubmed publisher
  86. Zhang J, Bu X, Wang H, Zhu Y, Geng Y, Nihira N, et al. Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance. Nature. 2018;553:91-95 pubmed publisher
  87. Wasiuk A, Testa J, Weidlick J, Sisson C, Vitale L, Widger J, et al. CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy. J Immunol. 2017;199:4110-4123 pubmed publisher
  88. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, et al. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. J Immunol. 2017;199:2777-2793 pubmed publisher
  89. Giampazolias E, Zunino B, Dhayade S, Bock F, Cloix C, Cao K, et al. Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency. Nat Cell Biol. 2017;19:1116-1129 pubmed publisher
  90. Billerbeck E, Wolfisberg R, Fahnøe U, Xiao J, Quirk C, Luna J, et al. Mouse models of acute and chronic hepacivirus infection. Science. 2017;357:204-208 pubmed publisher
  91. Gorvel L, Korenfeld D, Tung T, Klechevsky E. Dendritic Cell-Derived IL-32?: A Novel Inhibitory Cytokine of NK Cell Function. J Immunol. 2017;199:1290-1300 pubmed publisher
  92. Garcia Hernandez M, Uribe Uribe N, Espinosa González R, Kast W, Khader S, Rangel Moreno J. A Unique Cellular and Molecular Microenvironment Is Present in Tertiary Lymphoid Organs of Patients with Spontaneous Prostate Cancer Regression. Front Immunol. 2017;8:563 pubmed publisher
  93. Domae E, Hirai Y, Ikeo T, Goda S, Shimizu Y. Cytokine-mediated activation of human ex vivo-expanded V?9V?2 T cells. Oncotarget. 2017;8:45928-45942 pubmed publisher
  94. Tong A, Hashem H, Eid S, Allen F, Kingsley D, Huang A. Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma. Oncoimmunology. 2017;6:e1303586 pubmed publisher
  95. Djaoud Z, Guethlein L, Horowitz A, Azzi T, Nemat Gorgani N, Olive D, et al. Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and ?? T cells. J Exp Med. 2017;214:1827-1841 pubmed publisher
  96. Berthel A, Zoernig I, Valous N, Kahlert C, Klupp F, Ulrich A, et al. Detailed resolution analysis reveals spatial T cell heterogeneity in the invasive margin of colorectal cancer liver metastases associated with improved survival. Oncoimmunology. 2017;6:e1286436 pubmed publisher
  97. Klein J, Moses K, Zelinskyy G, Sody S, Buer J, Lang S, et al. Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth. Nat Commun. 2017;8:14600 pubmed publisher
  98. Su S, Liao J, Liu J, Huang D, He C, Chen F, et al. Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Res. 2017;27:461-482 pubmed publisher
  99. Collins A, Rothman N, Liu K, Reiner S. Eomesodermin and T-bet mark developmentally distinct human natural killer cells. JCI Insight. 2017;2:e90063 pubmed publisher
  100. Nishimura Y, Gautam R, Chun T, Sadjadpour R, Foulds K, Shingai M, et al. Early antibody therapy can induce long-lasting immunity to SHIV. Nature. 2017;543:559-563 pubmed publisher
  101. Egashira A, Morita M, Kumagai R, Taguchi K, Ueda M, Yamaguchi S, et al. Neuroendocrine carcinoma of the esophagus: Clinicopathological and immunohistochemical features of 14 cases. PLoS ONE. 2017;12:e0173501 pubmed publisher
  102. Cheuk S, Schlums H, Gallais Sérézal I, Martini E, Chiang S, Marquardt N, et al. CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin. Immunity. 2017;46:287-300 pubmed publisher
  103. Zamarin D, Holmgaard R, Ricca J, Plitt T, Palese P, Sharma P, et al. Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity. Nat Commun. 2017;8:14340 pubmed publisher
  104. Knudson K, Pritzl C, Saxena V, Altman A, Daniels M, Teixeiro E. NFκB-Pim-1-Eomesodermin axis is critical for maintaining CD8 T-cell memory quality. Proc Natl Acad Sci U S A. 2017;114:E1659-E1667 pubmed publisher
  105. Jeffery H, Jeffery L, Lutz P, Corrigan M, Webb G, Hirschfield G, et al. Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases. Clin Exp Immunol. 2017;188:394-411 pubmed publisher
  106. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed publisher
  107. Scott N, Rogers L, Prudova A, Brown N, Fortelny N, Overall C, et al. Interactome disassembly during apoptosis occurs independent of caspase cleavage. Mol Syst Biol. 2017;13:906 pubmed publisher
  108. Roberts E, Carnathan D, Li H, Shaw G, Silvestri G, Betts M. Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques. PLoS Pathog. 2016;12:e1006135 pubmed publisher
  109. Moroishi T, Hayashi T, Pan W, Fujita Y, Holt M, Qin J, et al. The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity. Cell. 2016;167:1525-1539.e17 pubmed publisher
  110. Ryan P, Sumaria N, Holland C, Bradford C, Izotova N, Grandjean C, et al. Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals. Proc Natl Acad Sci U S A. 2016;113:14378-14383 pubmed
  111. Hippen K, Watkins B, Tkachev V, Lemire A, Lehnen C, Riddle M, et al. Preclinical Testing of Antihuman CD28 Fab' Antibody in a Novel Nonhuman Primate Small Animal Rodent Model of Xenogenic Graft-Versus-Host Disease. Transplantation. 2016;100:2630-2639 pubmed publisher
  112. Galindo Albarrán A, López Portales O, Gutiérrez Reyna D, Rodríguez Jorge O, Sánchez Villanueva J, Ramirez Pliego O, et al. CD8+ T Cells from Human Neonates Are Biased toward an Innate Immune Response. Cell Rep. 2016;17:2151-2160 pubmed publisher
  113. Kadivar M, Petersson J, Svensson L, Marsal J. CD8??+ ?? T Cells: A Novel T Cell Subset with a Potential Role in Inflammatory Bowel Disease. J Immunol. 2016;197:4584-4592 pubmed
  114. Srivastava R, Khan A, Garg S, Syed S, Furness J, Vahed H, et al. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocula. J Virol. 2017;91: pubmed publisher
  115. Cuff A, Robertson F, Stegmann K, Pallett L, Maini M, Davidson B, et al. Eomeshi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation. J Immunol. 2016;197:4283-4291 pubmed
  116. Peters C, Häsler R, Wesch D, Kabelitz D. Human Vδ2 T cells are a major source of interleukin-9. Proc Natl Acad Sci U S A. 2016;113:12520-12525 pubmed
  117. Starobinets H, Ye J, Broz M, Barry K, Goldsmith J, Marsh T, et al. Antitumor adaptive immunity remains intact following inhibition of autophagy and antimalarial treatment. J Clin Invest. 2016;126:4417-4429 pubmed publisher
  118. Hu X, Valentin A, Dayton F, Kulkarni V, Alicea C, Rosati M, et al. DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV. J Immunol. 2016;197:3999-4013 pubmed
  119. Chandele A, Sewatanon J, Gunisetty S, Singla M, Onlamoon N, Akondy R, et al. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India. J Virol. 2016;90:11259-11278 pubmed
  120. Klotz L, Kuzmanov I, Hucke S, Gross C, Posevitz V, Dreykluft A, et al. B7-H1 shapes T-cell-mediated brain endothelial cell dysfunction and regional encephalitogenicity in spontaneous CNS autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6182-E6191 pubmed
  121. Willemen Y, Van den Bergh J, Bonte S, Anguille S, Heirman C, Stein B, et al. The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells. Oncotarget. 2016;7:73960-73970 pubmed publisher
  122. Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832 pubmed publisher
  123. Lewis G, Wehrens E, Labarta Bajo L, Streeck H, Zuniga E. TGF-? receptor maintains CD4 T helper cell identity during chronic viral infections. J Clin Invest. 2016;126:3799-3813 pubmed publisher
  124. Jiang J, Chen X, An H, Yang B, Zhang F, Cheng X. Enhanced immune response of MAIT cells in tuberculous pleural effusions depends on cytokine signaling. Sci Rep. 2016;6:32320 pubmed publisher
  125. Torrelo A, Noguera Morel L, Hernandez Martin A, Clemente D, Barja J, Buzon L, et al. Recurrent lipoatrophic panniculitis of children. J Eur Acad Dermatol Venereol. 2017;31:536-543 pubmed publisher
  126. Hervier B, Perez M, Allenbach Y, Devilliers H, Cohen F, Uzunhan Y, et al. Involvement of NK Cells and NKp30 Pathway in Antisynthetase Syndrome. J Immunol. 2016;197:1621-30 pubmed publisher
  127. Leong Y, Chen Y, Ong H, Wu D, Man K, Deléage C, et al. CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol. 2016;17:1187-96 pubmed publisher
  128. Kritikou J, Dahlberg C, Baptista M, Wagner A, Banerjee P, Gwalani L, et al. IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo. Sci Rep. 2016;6:30636 pubmed publisher
  129. Hirayama M, Tomita Y, Yuno A, Tsukamoto H, Senju S, Imamura Y, et al. An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs. Oncoimmunology. 2016;5:e1123368 pubmed publisher
  130. Wang Y, Sun H, Wang J, Wang H, Meng L, Xu C, et al. DNA-PK-mediated phosphorylation of EZH2 regulates the DNA damage-induced apoptosis to maintain T-cell genomic integrity. Cell Death Dis. 2016;7:e2316 pubmed publisher
  131. Franzese O, Palermo B, Di Donna C, Sperduti I, Ferraresi V, Stabile H, et al. Polyfunctional Melan-A-specific tumor-reactive CD8(+) T cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS. Oncoimmunology. 2016;5:e1114203 pubmed publisher
  132. Ashizawa T, Iizuka A, Nonomura C, Kondou R, Maeda C, Miyata H, et al. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse. Clin Cancer Res. 2017;23:149-158 pubmed publisher
  133. Gorman M, Poddar S, Farzan M, Diamond M. The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis. J Virol. 2016;90:8212-25 pubmed publisher
  134. Xu Y, Chaudhury A, Zhang M, Savoldo B, Metelitsa L, Rodgers J, et al. Glycolysis determines dichotomous regulation of T cell subsets in hypoxia. J Clin Invest. 2016;126:2678-88 pubmed publisher
  135. Neumann B, Shi T, Gan L, Klippert A, Daskalaki M, Stolte Leeb N, et al. Comprehensive panel of cross-reacting monoclonal antibodies for analysis of different immune cells and their distribution in the common marmoset (Callithrix jacchus). J Med Primatol. 2016;45:139-46 pubmed publisher
  136. Golombeck K, Bönte K, Mönig C, van Loo K, Hartwig M, Schwindt W, et al. Evidence of a pathogenic role for CD8(+) T cells in anti-GABAB receptor limbic encephalitis. Neurol Neuroimmunol Neuroinflamm. 2016;3:e232 pubmed publisher
  137. Yin W, Tong S, Zhang Q, Shao J, Liu Q, Peng H, et al. Functional dichotomy of Vδ2 γδ T cells in chronic hepatitis C virus infections: role in cytotoxicity but not for IFN-γ production. Sci Rep. 2016;6:26296 pubmed publisher
  138. Marafini I, Monteleone I, Di Fusco D, Sedda S, Cupi M, Fina D, et al. Celiac Disease-Related Inflammation Is Marked by Reduction of Nkp44/Nkp46-Double Positive Natural Killer Cells. PLoS ONE. 2016;11:e0155103 pubmed publisher
  139. Urban S, Berg L, Welsh R. Type 1 interferon licenses naïve CD8 T cells to mediate anti-viral cytotoxicity. Virology. 2016;493:52-9 pubmed publisher
  140. Lee Chang C, Bodogai M, Moritoh K, Chen X, Wersto R, Sen R, et al. Aging Converts Innate B1a Cells into Potent CD8+ T Cell Inducers. J Immunol. 2016;196:3385-97 pubmed publisher
  141. McGranahan N, Furness A, Rosenthal R, Ramskov S, Lyngaa R, Saini S, et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science. 2016;351:1463-9 pubmed publisher
  142. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  143. Luo C, Liao W, Dadi S, Toure A, Li M. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity. Nature. 2016;529:532-6 pubmed publisher
  144. Lucas T, Richner J, Diamond M. The Interferon-Stimulated Gene Ifi27l2a Restricts West Nile Virus Infection and Pathogenesis in a Cell-Type- and Region-Specific Manner. J Virol. 2015;90:2600-15 pubmed publisher
  145. Mangan M, Bird C, Kaiserman D, Matthews A, Hitchen C, Steer D, et al. A Novel Serpin Regulatory Mechanism: SerpinB9 IS REVERSIBLY INHIBITED BY VICINAL DISULFIDE BOND FORMATION IN THE REACTIVE CENTER LOOP. J Biol Chem. 2016;291:3626-38 pubmed publisher
  146. Höftberger R, Leisser M, Bauer J, Lassmann H. Autoimmune encephalitis in humans: how closely does it reflect multiple sclerosis ?. Acta Neuropathol Commun. 2015;3:80 pubmed publisher
  147. Zhao E, Maj T, Kryczek I, Li W, Wu K, Zhao L, et al. Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction. Nat Immunol. 2016;17:95-103 pubmed publisher
  148. Deisting W, Raum T, Kufer P, Baeuerle P, Münz M. Impact of Diverse Immune Evasion Mechanisms of Cancer Cells on T Cells Engaged by EpCAM/CD3-Bispecific Antibody Construct AMG 110. PLoS ONE. 2015;10:e0141669 pubmed publisher
  149. Kurtulus S, Sakuishi K, Ngiow S, Joller N, Tan D, Teng M, et al. TIGIT predominantly regulates the immune response via regulatory T cells. J Clin Invest. 2015;125:4053-62 pubmed publisher
  150. Marković Lipkovski J, Životić M, Müller C, Tampe B, Ćirović S, Vještica J, et al. Variable Expression of Neural Cell Adhesion Molecule Isoforms in Renal Tissue: Possible Role in Incipient Renal Fibrosis. PLoS ONE. 2015;10:e0137028 pubmed publisher
  151. Pearce V, Bouabe H, MacQueen A, Carbonaro V, Okkenhaug K. PI3Kδ Regulates the Magnitude of CD8+ T Cell Responses after Challenge with Listeria monocytogenes. J Immunol. 2015;195:3206-17 pubmed publisher
  152. Leeansyah E, Svärd J, Dias J, Buggert M, Nyström J, Quigley M, et al. Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog. 2015;11:e1005072 pubmed publisher
  153. Weist B, Wehler P, El Ahmad L, Schmueck Henneresse M, Millward J, Nienen M, et al. A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients. Kidney Int. 2015;88:1293-1303 pubmed publisher
  154. Littwitz Salomon E, Akhmetzyanova I, Vallet C, Francois S, Dittmer U, Gibbert K. Activated regulatory T cells suppress effector NK cell responses by an IL-2-mediated mechanism during an acute retroviral infection. Retrovirology. 2015;12:66 pubmed publisher
  155. Vogel A, Brown D. Single-Dose CpG Immunization Protects Against a Heterosubtypic Challenge and Generates Antigen-Specific Memory T Cells. Front Immunol. 2015;6:327 pubmed publisher
  156. Marshall M, Pattu V, Halimani M, Maier Peuschel M, Müller M, Becherer U, et al. VAMP8-dependent fusion of recycling endosomes with the plasma membrane facilitates T lymphocyte cytotoxicity. J Cell Biol. 2015;210:135-51 pubmed publisher
  157. Herz J, Johnson K, McGavern D. Therapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cells. J Exp Med. 2015;212:1153-69 pubmed publisher
  158. Liechtenstein T, Perez Janices N, Blanco Luquin I, Goyvaerts C, Schwarze J, Dufait I, et al. Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy. Oncoimmunology. 2014;3:e945378 pubmed
  159. Schmueck Henneresse M, Sharaf R, Vogt K, Weist B, Landwehr Kenzel S, Fuehrer H, et al. Peripheral blood-derived virus-specific memory stem T cells mature to functional effector memory subsets with self-renewal potency. J Immunol. 2015;194:5559-67 pubmed publisher
  160. Sharma S, Chintala N, Vadrevu S, Patel J, Karbowniczek M, Markiewski M. Pulmonary alveolar macrophages contribute to the premetastatic niche by suppressing antitumor T cell responses in the lungs. J Immunol. 2015;194:5529-38 pubmed publisher
  161. Jeon Y, Kim J, Sung J, Han J, Ko Y. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features. Hum Pathol. 2015;46:981-90 pubmed publisher
  162. Chen M, Hu P, Ling N, Peng H, Lei Y, Hu H, et al. Enhanced functions of peripheral γδ T cells in chronic hepatitis B infection during interferon α treatment in vivo and in vitro. PLoS ONE. 2015;10:e0120086 pubmed publisher
  163. Rao E, Zhang Y, Zhu G, Hao J, Persson X, Egilmez N, et al. Deficiency of AMPK in CD8+ T cells suppresses their anti-tumor function by inducing protein phosphatase-mediated cell death. Oncotarget. 2015;6:7944-58 pubmed
  164. Tomasini D, Niccoli A, Crivelli F. Pagetoid reticulosis tumor cells with double expression of TCRγδ and TCRαβ: an off-target phenomenon or genuine expression?. J Cutan Pathol. 2015;42:427-34 pubmed publisher
  165. Ebsen H, Lettau M, Kabelitz D, Janssen O. Subcellular localization and activation of ADAM proteases in the context of FasL shedding in T lymphocytes. Mol Immunol. 2015;65:416-28 pubmed publisher
  166. Claiborne D, Prince J, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad Sci U S A. 2015;112:E1480-9 pubmed publisher
  167. Marquardt N, Béziat V, Nyström S, Hengst J, Ivarsson M, Kekäläinen E, et al. Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells. J Immunol. 2015;194:2467-71 pubmed publisher
  168. Hu Z, Blackman M, Kaye K, Usherwood E. Functional heterogeneity in the CD4+ T cell response to murine γ-herpesvirus 68. J Immunol. 2015;194:2746-56 pubmed publisher
  169. Bhela S, Kempsell C, Manohar M, Dominguez Villar M, Griffin R, Bhatt P, et al. Nonapoptotic and extracellular activity of granzyme B mediates resistance to regulatory T cell (Treg) suppression by HLA-DR-CD25hiCD127lo Tregs in multiple sclerosis and in response to IL-6. J Immunol. 2015;194:2180-9 pubmed publisher
  170. Triplett T, Tucker C, Triplett K, Alderman Z, Sun L, Ling L, et al. STAT3 Signaling Is Required for Optimal Regression of Large Established Tumors in Mice Treated with Anti-OX40 and TGFβ Receptor Blockade. Cancer Immunol Res. 2015;3:526-35 pubmed publisher
  171. Srivastava R, Khan A, Spencer D, Vahed H, Lopes P, Thai N, et al. HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgenic. J Immunol. 2015;194:2232-48 pubmed publisher
  172. Dimova T, Brouwer M, Gosselin F, Tassignon J, Leo O, Donner C, et al. Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire. Proc Natl Acad Sci U S A. 2015;112:E556-65 pubmed publisher
  173. Khan A, Srivastava R, Spencer D, Garg S, Fremgen D, Vahed H, et al. Phenotypic and functional characterization of herpes simplex virus glycoprotein B epitope-specific effector and memory CD8+ T cells from symptomatic and asymptomatic individuals with ocular herpes. J Virol. 2015;89:3776-92 pubmed publisher
  174. Zhang P, Lu X, Tao K, Shi L, Li W, Wang G, et al. Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinoma. J Surg Res. 2015;194:107-13 pubmed publisher
  175. Grøndahl Rosado C, Bønsdorff T, Brun Hansen H, Storset A. NCR1+ cells in dogs show phenotypic characteristics of natural killer cells. Vet Res Commun. 2015;39:19-30 pubmed publisher
  176. Wang L, Wang G, Gao T. Acneiform primary cutaneous CD4-positive small/medium pleomorphic T-cell lymphoma with prominent necrosis. J Cutan Pathol. 2015;42:265-70 pubmed publisher
  177. Lester L, Ewalt M, Warnke R, Kim J. Systemic panniculitis-like T-cell lymphoma with involvement of mesenteric fat and subcutis. J Cutan Pathol. 2015;42:46-9 pubmed publisher
  178. Mouchacca P, Chasson L, Frick M, Foray C, Schmitt Verhulst A, Boyer C. Visualization of granzyme B-expressing CD8 T cells during primary and secondary immune responses to Listeria monocytogenes. Immunology. 2015;145:24-33 pubmed publisher
  179. Wang X, Sumida H, Cyster J. GPR18 is required for a normal CD8αα intestinal intraepithelial lymphocyte compartment. J Exp Med. 2014;211:2351-9 pubmed publisher
  180. Sullivan E, Jeha S, Kang G, Cheng C, Rooney B, Holladay M, et al. NK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual disease. Clin Cancer Res. 2014;20:5986-94 pubmed publisher
  181. Srivastava P, Paluch B, Matsuzaki J, James S, Collamat Lai G, Karbach J, et al. Immunomodulatory action of SGI-110, a hypomethylating agent, in acute myeloid leukemia cells and xenografts. Leuk Res. 2014;38:1332-41 pubmed publisher
  182. Urban S, Welsh R. Out-of-sequence signal 3 as a mechanism for virus-induced immune suppression of CD8 T cell responses. PLoS Pathog. 2014;10:e1004357 pubmed publisher
  183. Kobayashi T, Hamaguchi Y, Hasegawa M, Fujimoto M, Takehara K, Matsushita T. B cells promote tumor immunity against B16F10 melanoma. Am J Pathol. 2014;184:3120-9 pubmed publisher
  184. Antsiferova O, Müller A, Rämer P, Chijioke O, Chatterjee B, Raykova A, et al. Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice. PLoS Pathog. 2014;10:e1004333 pubmed publisher
  185. Penaloza MacMaster P, Kamphorst A, Wieland A, Araki K, Iyer S, West E, et al. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection. J Exp Med. 2014;211:1905-18 pubmed publisher
  186. Weist B, Schmueck M, Fuehrer H, Sattler A, Reinke P, Babel N. The role of CD4(+) T cells in BKV-specific T cell immunity. Med Microbiol Immunol. 2014;203:395-408 pubmed publisher
  187. Boding L, Hansen A, Meroni G, Johansen B, Braunstein T, Bonefeld C, et al. Midline 1 directs lytic granule exocytosis and cytotoxicity of mouse killer T cells. Eur J Immunol. 2014;44:3109-18 pubmed publisher
  188. Baker G, Chockley P, Yadav V, Doherty R, Ritt M, Sivaramakrishnan S, et al. Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity. Cancer Res. 2014;74:5079-90 pubmed publisher
  189. Pegram H, Purdon T, van Leeuwen D, Curran K, Giralt S, Barker J, et al. IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia. Leukemia. 2015;29:415-22 pubmed publisher
  190. Smith N, Wissink E, Wang J, Pinello J, Davenport M, Grimson A, et al. Rapid proliferation and differentiation impairs the development of memory CD8+ T cells in early life. J Immunol. 2014;193:177-84 pubmed publisher
  191. Vargas A, Zhou S, Ethier Chiasson M, Flipo D, Lafond J, Gilbert C, et al. Syncytin proteins incorporated in placenta exosomes are important for cell uptake and show variation in abundance in serum exosomes from patients with preeclampsia. FASEB J. 2014;28:3703-19 pubmed publisher
  192. Teixeira C, Gomes R, Oliveira F, Meneses C, Gilmore D, Elnaiem D, et al. Characterization of the early inflammatory infiltrate at the feeding site of infected sand flies in mice protected from vector-transmitted Leishmania major by exposure to uninfected bites. PLoS Negl Trop Dis. 2014;8:e2781 pubmed publisher
  193. Pick J, Arra A, Lingel H, Hegel J, Huber M, Nishanth G, et al. CTLA-4 (CD152) enhances the Tc17 differentiation program. Eur J Immunol. 2014;44:2139-52 pubmed publisher
  194. Ntranos A, Hall O, Robinson D, Grishkan I, Schott J, Tosi D, et al. FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway. J Neuroimmunol. 2014;270:13-21 pubmed publisher
  195. Prinz P, Mendler A, Brech D, Masouris I, Oberneder R, Noessner E. NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention. Int J Cancer. 2014;135:1832-41 pubmed publisher
  196. Sleiman M, Brons N, Kaoma T, Dogu F, Villa Forte A, Lenoble P, et al. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules. J Immunol. 2014;192:2602-10 pubmed publisher
  197. Bacchetta R, Lucarelli B, Sartirana C, Gregori S, Lupo Stanghellini M, Miqueu P, et al. Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells. Front Immunol. 2014;5:16 pubmed publisher
  198. Poonia B, Pauza C. Levels of CD56+TIM-3- effector CD8 T cells distinguish HIV natural virus suppressors from patients receiving antiretroviral therapy. PLoS ONE. 2014;9:e88884 pubmed publisher
  199. Hagn M, Blackwell S, Beyer T, Ebel V, Fabricius D, Lindner S, et al. B-CLL cells acquire APC- and CTL-like phenotypic characteristics after stimulation with CpG ODN and IL-21. Int Immunol. 2014;26:383-95 pubmed publisher
  200. Kulkarni V, Valentin A, Rosati M, Alicea C, Singh A, Jalah R, et al. Altered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques. PLoS ONE. 2014;9:e86254 pubmed publisher
  201. Joedicke J, Dietze K, Zelinskyy G, Dittmer U. The phenotype and activation status of regulatory T cells during Friend retrovirus infection. Virol Sin. 2014;29:48-60 pubmed publisher
  202. Kim E, Gasper D, Lee S, Plisch E, Svaren J, Suresh M. Bach2 regulates homeostasis of Foxp3+ regulatory T cells and protects against fatal lung disease in mice. J Immunol. 2014;192:985-95 pubmed publisher
  203. Tuli A, Thiery J, James A, Michelet X, Sharma M, Garg S, et al. Arf-like GTPase Arl8b regulates lytic granule polarization and natural killer cell-mediated cytotoxicity. Mol Biol Cell. 2013;24:3721-35 pubmed publisher
  204. Lauterbach H, Pätzold J, Kassub R, Bathke B, Brinkmann K, Chaplin P, et al. Genetic Adjuvantation of Recombinant MVA with CD40L Potentiates CD8 T Cell Mediated Immunity. Front Immunol. 2013;4:251 pubmed publisher
  205. Durant L, Makris S, Voorburg C, Loebbermann J, Johansson C, Openshaw P. Regulatory T cells prevent Th2 immune responses and pulmonary eosinophilia during respiratory syncytial virus infection in mice. J Virol. 2013;87:10946-54 pubmed publisher
  206. Nakajima K, Maekawa Y, Kataoka K, Ishifune C, Nishida J, Arimochi H, et al. The ARNT-STAT3 axis regulates the differentiation of intestinal intraepithelial TCR???CD8??? cells. Nat Commun. 2013;4:2112 pubmed publisher
  207. Tejera M, Kim E, Sullivan J, Plisch E, Suresh M. FoxO1 controls effector-to-memory transition and maintenance of functional CD8 T cell memory. J Immunol. 2013;191:187-99 pubmed publisher
  208. Hu Z, Zhang W, Usherwood E. Regulatory CD8+ T cells associated with erosion of immune surveillance in persistent virus infection suppress in vitro and have a reversible proliferative defect. J Immunol. 2013;191:312-22 pubmed publisher
  209. Fischer M, Wimmer I, Hoftberger R, Gerlach S, Haider L, Zrzavy T, et al. Disease-specific molecular events in cortical multiple sclerosis lesions. Brain. 2013;136:1799-815 pubmed publisher
  210. Manzke N, Akhmetzyanova I, Hasenkrug K, Trilling M, Zelinskyy G, Dittmer U. CD4+ T cells develop antiretroviral cytotoxic activity in the absence of regulatory T cells and CD8+ T cells. J Virol. 2013;87:6306-13 pubmed publisher
  211. Mellor Heineke S, Villanueva J, Jordan M, Marsh R, Zhang K, Bleesing J, et al. Elevated Granzyme B in Cytotoxic Lymphocytes is a Signature of Immune Activation in Hemophagocytic Lymphohistiocytosis. Front Immunol. 2013;4:72 pubmed publisher
  212. Schmitt D, O Dee D, Brown M, Horzempa J, Russo B, Morel P, et al. Role of NK cells in host defense against pulmonary type A Francisella tularensis infection. Microbes Infect. 2013;15:201-11 pubmed publisher
  213. Deguine J, Breart B, Lemaitre F, Bousso P. Cutting edge: tumor-targeting antibodies enhance NKG2D-mediated NK cell cytotoxicity by stabilizing NK cell-tumor cell interactions. J Immunol. 2012;189:5493-7 pubmed publisher
  214. Penaloza MacMaster P, Provine N, Ra J, Borducchi E, McNally A, Simmons N, et al. Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectors. J Virol. 2013;87:1373-84 pubmed publisher
  215. Jalah R, Patel V, Kulkarni V, Rosati M, Alicea C, Ganneru B, et al. IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques. Hum Vaccin Immunother. 2012;8:1620-9 pubmed publisher
  216. Bhadra R, Khan I. IL-7 and IL-15 do not synergize during CD8 T cell recall response against an obligate intracellular parasite. Microbes Infect. 2012;14:1160-8 pubmed publisher
  217. Walsh K, Teijaro J, Zuniga E, Welch M, Fremgen D, Blackburn S, et al. Toll-like receptor 7 is required for effective adaptive immune responses that prevent persistent virus infection. Cell Host Microbe. 2012;11:643-53 pubmed publisher
  218. Chang P, Lee S, Hu X, Davey G, Duan G, Cho J, et al. Breakdown in repression of IFN-? mRNA leads to accumulation of self-reactive effector CD8+ T cells. J Immunol. 2012;189:701-10 pubmed publisher
  219. Zhang N, Bevan M. TGF-? signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferation. Nat Immunol. 2012;13:667-73 pubmed publisher
  220. Robb R, Lineburg K, Kuns R, Wilson Y, Raffelt N, Olver S, et al. Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantation. Blood. 2012;119:5898-908 pubmed publisher
  221. Ribeiro Dos Santos P, Turnbull E, Monteiro M, Legrand A, Conrod K, Baalwa J, et al. Chronic HIV infection affects the expression of the 2 transcription factors required for CD8 T-cell differentiation into cytolytic effectors. Blood. 2012;119:4928-38 pubmed publisher
  222. Hutnick N, Myles D, Hirao L, Scott V, Ferraro B, Khan A, et al. An optimized SIV DNA vaccine can serve as a boost for Ad5 and provide partial protection from a high-dose SIVmac251 challenge. Vaccine. 2012;30:3202-8 pubmed publisher
  223. Loebbermann J, Schnoeller C, Thornton H, Durant L, Sweeney N, Schuijs M, et al. IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice. PLoS ONE. 2012;7:e32371 pubmed publisher
  224. CLAY C, Donart N, Fomukong N, Knight J, Lei W, Price L, et al. Primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge. J Virol. 2012;86:4234-44 pubmed publisher
  225. Loebbermann J, Thornton H, Durant L, Sparwasser T, Webster K, Sprent J, et al. Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection. Mucosal Immunol. 2012;5:161-72 pubmed publisher
  226. Salti S, Hammelev E, Grewal J, Reddy S, Zemple S, Grossman W, et al. Granzyme B regulates antiviral CD8+ T cell responses. J Immunol. 2011;187:6301-9 pubmed publisher
  227. Adoro S, McCaughtry T, Erman B, Alag A, Van Laethem F, Park J, et al. Coreceptor gene imprinting governs thymocyte lineage fate. EMBO J. 2012;31:366-77 pubmed publisher
  228. Randall K, Chan S, Ma C, Fung I, Mei Y, Yabas M, et al. DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J Exp Med. 2011;208:2305-20 pubmed publisher
  229. Vargas Inchaustegui D, Demberg T, Robert Guroff M. A CD8?(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities. Immunology. 2011;134:326-40 pubmed publisher
  230. Brincks E, Gurung P, Langlois R, Hemann E, Legge K, Griffith T. The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL. J Immunol. 2011;187:4581-8 pubmed publisher
  231. Mahnke Y, Saqr A, Hazenfeld S, Brady R, Roederer M, Subbramanian R. Age-related changes in durability and function of vaccine-elicited influenza-specific CD4(+) T-cell responses. Vaccine. 2011;29:8606-14 pubmed publisher
  232. Hsieh S, Lin J, Huang J, Wu S, Chu C, Kung J, et al. Immunization with apoptotic phagocytes containing Histoplasma capsulatum activates functional CD8(+) T cells to protect against histoplasmosis. Infect Immun. 2011;79:4493-502 pubmed publisher
  233. Lee D, Yang J, Lee S, Won C, Chang S, Lee M, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinical and pathologic study of 14 korean patients. Ann Dermatol. 2011;23:329-37 pubmed publisher
  234. Desmarets M, Mylvaganam G, Waller E, Josephson C, Pack C, Lukacher A, et al. Minor antigens on transfused RBCs crossprime CD8 T cells but do not induce full effector function. Am J Transplant. 2011;11:1825-34 pubmed publisher
  235. Zelinskyy G, Myers L, Dietze K, Gibbert K, Roggendorf M, Liu J, et al. Virus-specific CD8+ T cells upregulate programmed death-1 expression during acute friend retrovirus infection but are highly cytotoxic and control virus replication. J Immunol. 2011;187:3730-7 pubmed publisher
  236. Ruffell B, Au A, Rugo H, Esserman L, Hwang E, Coussens L. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A. 2012;109:2796-801 pubmed publisher
  237. Robb R, Kreijveld E, Kuns R, Wilson Y, Olver S, Don A, et al. Type I-IFNs control GVHD and GVL responses after transplantation. Blood. 2011;118:3399-409 pubmed publisher
  238. D Eliseo D, Manzi L, Merendino N, Velotti F. Docosahexaenoic acid inhibits invasion of human RT112 urinary bladder and PT45 pancreatic carcinoma cells via down-modulation of granzyme B expression. J Nutr Biochem. 2012;23:452-7 pubmed publisher
  239. Tate M, Brooks A, Reading P, Mintern J. Neutrophils sustain effective CD8(+) T-cell responses in the respiratory tract following influenza infection. Immunol Cell Biol. 2012;90:197-205 pubmed publisher
  240. Meythaler M, Wang Z, Martinot A, Pryputniewicz S, Kasheta M, McClure H, et al. Early induction of polyfunctional simian immunodeficiency virus (SIV)-specific T lymphocytes and rapid disappearance of SIV from lymph nodes of sooty mangabeys during primary infection. J Immunol. 2011;186:5151-61 pubmed publisher
  241. Haque A, Best S, Amante F, Ammerdorffer A, de Labastida F, Pereira T, et al. High parasite burdens cause liver damage in mice following Plasmodium berghei ANKA infection independently of CD8(+) T cell-mediated immune pathology. Infect Immun. 2011;79:1882-8 pubmed publisher
  242. Kallies A, Carotta S, Huntington N, Bernard N, Tarlinton D, Smyth M, et al. A role for Blimp1 in the transcriptional network controlling natural killer cell maturation. Blood. 2011;117:1869-79 pubmed publisher
  243. Hubert S, Rissiek B, Klages K, Huehn J, Sparwasser T, Haag F, et al. Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathway. J Exp Med. 2010;207:2561-8 pubmed publisher
  244. Klages K, Mayer C, Lahl K, Loddenkemper C, Teng M, Ngiow S, et al. Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma. Cancer Res. 2010;70:7788-99 pubmed publisher
  245. von Gegerfelt A, Valentin A, Alicea C, Van Rompay K, Marthas M, Montefiori D, et al. Emergence of simian immunodeficiency virus-specific cytotoxic CD4+ T cells and increased humoral responses correlate with control of rebounding viremia in CD8-depleted macaques infected with Rev-independent live-attenuated simian immunodeficiency vir. J Immunol. 2010;185:3348-58 pubmed publisher
  246. Lin P, Sun L, Thibodeaux S, Ludwig S, Vadlamudi R, Hurez V, et al. B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responses. J Immunol. 2010;185:2747-53 pubmed publisher
  247. Yuen T, Flesch I, Hollett N, Dobson B, Russell T, Fahrer A, et al. Analysis of A47, an immunoprevalent protein of vaccinia virus, leads to a reevaluation of the total antiviral CD8+ T cell response. J Virol. 2010;84:10220-9 pubmed publisher
  248. Antonelli L, Mahnke Y, Hodge J, Porter B, Barber D, DerSimonian R, et al. Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome. Blood. 2010;116:3818-27 pubmed publisher
  249. Rout N, Else J, Yue S, Connole M, Exley M, Kaur A. Heterogeneity in phenotype and function of CD8+ and CD4/CD8 double-negative Natural Killer T cell subsets in sooty mangabeys. J Med Primatol. 2010;39:224-34 pubmed publisher
  250. Cairo C, Armstrong C, Cummings J, Deetz C, Tan M, Lu C, et al. Impact of age, gender, and race on circulating ?? T cells. Hum Immunol. 2010;71:968-75 pubmed publisher
  251. Tait E, Jordan K, Dupont C, Harris T, Gregg B, Wilson E, et al. Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells. J Immunol. 2010;185:1502-12 pubmed publisher
  252. Marshall H, Prince A, Berg L, Welsh R. IFN-alpha beta and self-MHC divert CD8 T cells into a distinct differentiation pathway characterized by rapid acquisition of effector functions. J Immunol. 2010;185:1419-28 pubmed publisher
  253. Tran Thang N, Derouazi M, Philippin G, Arcidiaco S, Di Berardino Besson W, Masson F, et al. Immune infiltration of spontaneous mouse astrocytomas is dominated by immunosuppressive cells from early stages of tumor development. Cancer Res. 2010;70:4829-39 pubmed publisher
  254. Reeves R, Gillis J, Wong F, Yu Y, Connole M, Johnson R. CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection. Blood. 2010;115:4439-46 pubmed publisher
  255. Thiery J, Keefe D, Saffarian S, Martinvalet D, Walch M, Boucrot E, et al. Perforin activates clathrin- and dynamin-dependent endocytosis, which is required for plasma membrane repair and delivery of granzyme B for granzyme-mediated apoptosis. Blood. 2010;115:1582-93 pubmed publisher
  256. Waugh C, Sinclair L, Finlay D, Bayascas J, Cantrell D. Phosphoinositide (3,4,5)-triphosphate binding to phosphoinositide-dependent kinase 1 regulates a protein kinase B/Akt signaling threshold that dictates T-cell migration, not proliferation. Mol Cell Biol. 2009;29:5952-62 pubmed publisher
  257. Zelinskyy G, Dietze K, Hüsecken Y, Schimmer S, Nair S, Werner T, et al. The regulatory T-cell response during acute retroviral infection is locally defined and controls the magnitude and duration of the virus-specific cytotoxic T-cell response. Blood. 2009;114:3199-207 pubmed publisher
  258. Hagn M, Schwesinger E, Ebel V, Sontheimer K, Maier J, Beyer T, et al. Human B cells secrete granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21. J Immunol. 2009;183:1838-45 pubmed publisher
  259. Moffat J, Gebhardt T, Doherty P, Turner S, Mintern J. Granzyme A expression reveals distinct cytolytic CTL subsets following influenza A virus infection. Eur J Immunol. 2009;39:1203-10 pubmed publisher
  260. Brown D, Kamperschroer C, Dilzer A, Roberts D, Swain S. IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4+ T cells. Cell Immunol. 2009;257:69-79 pubmed publisher
  261. Aramaki T, Ida H, Izumi Y, Fujikawa K, Huang M, Arima K, et al. A significantly impaired natural killer cell activity due to a low activity on a per-cell basis in rheumatoid arthritis. Mod Rheumatol. 2009;19:245-52 pubmed publisher
  262. Hamada H, Garcia Hernandez M, Reome J, Misra S, Strutt T, McKinstry K, et al. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol. 2009;182:3469-81 pubmed publisher
  263. Ribeiro de Almeida C, Heath H, Krpic S, Dingjan G, van Hamburg J, Bergen I, et al. Critical role for the transcription regulator CCCTC-binding factor in the control of Th2 cytokine expression. J Immunol. 2009;182:999-1010 pubmed
  264. Huntington N, Legrand N, Alves N, Jaron B, Weijer K, Plet A, et al. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med. 2009;206:25-34 pubmed publisher
  265. Brincks E, Katewa A, Kucaba T, Griffith T, Legge K. CD8 T cells utilize TRAIL to control influenza virus infection. J Immunol. 2008;181:4918-25 pubmed
  266. Jenkins M, Mintern J, La Gruta N, Kedzierska K, Doherty P, Turner S. Cell cycle-related acquisition of cytotoxic mediators defines the progressive differentiation to effector status for virus-specific CD8+ T cells. J Immunol. 2008;181:3818-22 pubmed
  267. Lages C, Suffia I, Velilla P, Huang B, Warshaw G, Hildeman D, et al. Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation. J Immunol. 2008;181:1835-48 pubmed
  268. Cummings J, Cairo C, Armstrong C, Davis C, Pauza C. Impacts of HIV infection on Vgamma2Vdelta2 T cell phenotype and function: a mechanism for reduced tumor immunity in AIDS. J Leukoc Biol. 2008;84:371-9 pubmed publisher
  269. Chiarle R, Martinengo C, Mastini C, Ambrogio C, D Escamard V, Forni G, et al. The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination. Nat Med. 2008;14:676-80 pubmed publisher
  270. Sridhar S, Reyes Sandoval A, Draper S, Moore A, Gilbert S, Gao G, et al. Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A. J Virol. 2008;82:3822-33 pubmed publisher
  271. Ahonen C, Wasiuk A, Fuse S, Turk M, Ernstoff M, Suriawinata A, et al. Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines. Blood. 2008;111:3116-25 pubmed publisher
  272. Hickman H, Takeda K, Skon C, Murray F, Hensley S, Loomis J, et al. Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes. Nat Immunol. 2008;9:155-65 pubmed publisher
  273. Wagner C, Stegmaier S, Hänsch G. Expression of granzyme B in peripheral blood polymorphonuclear neutrophils (PMN), myeloid cell lines and in PMN derived from haemotopoietic stem cells in vitro. Mol Immunol. 2008;45:1761-6 pubmed
  274. Zelinskyy G, Balkow S, Schimmer S, Werner T, Simon M, Dittmer U. The level of friend retrovirus replication determines the cytolytic pathway of CD8+ T-cell-mediated pathogen control. J Virol. 2007;81:11881-90 pubmed
  275. Chan K, Kaur A. Flow cytometric detection of degranulation reveals phenotypic heterogeneity of degranulating CMV-specific CD8+ T lymphocytes in rhesus macaques. J Immunol Methods. 2007;325:20-34 pubmed
  276. Masson F, Calzascia T, Di Berardino Besson W, De Tribolet N, Dietrich P, Walker P. Brain microenvironment promotes the final functional maturation of tumor-specific effector CD8+ T cells. J Immunol. 2007;179:845-53 pubmed
  277. Jenkins M, Kedzierska K, Doherty P, Turner S. Heterogeneity of effector phenotype for acute phase and memory influenza A virus-specific CTL. J Immunol. 2007;179:64-70 pubmed
  278. Love V, Grabie N, Duramad P, Stavrakis G, Sharpe A, Lichtman A. CTLA-4 ablation and interleukin-12 driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes. Circ Res. 2007;101:248-57 pubmed
  279. Romagnani C, Juelke K, Falco M, Morandi B, D Agostino A, Costa R, et al. CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J Immunol. 2007;178:4947-55 pubmed
  280. Coquet J, Kyparissoudis K, Pellicci D, Besra G, Berzins S, Smyth M, et al. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J Immunol. 2007;178:2827-34 pubmed
  281. Tao J, Gao Y, Li M, He W, Chen L, Harvev B, et al. JNK2 negatively regulates CD8+ T cell effector function and anti-tumor immune response. Eur J Immunol. 2007;37:818-29 pubmed
  282. Yang Z, Novak A, Ziesmer S, Witzig T, Ansell S. Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma. Cancer Res. 2006;66:10145-52 pubmed
  283. Obar J, Fuse S, Leung E, Bellfy S, Usherwood E. Gammaherpesvirus persistence alters key CD8 T-cell memory characteristics and enhances antiviral protection. J Virol. 2006;80:8303-15 pubmed
  284. Macchia I, Gauduin M, Kaur A, Johnson R. Expression of CD8alpha identifies a distinct subset of effector memory CD4+ T lymphocytes. Immunology. 2006;119:232-42 pubmed
  285. McIlroy D, Meyer L, Dudoit Y, Samri A, Delfraissy J, Autran B, et al. Polymorphism in the proximal promoter region of the perforin gene and its impact on the course of HIV infection. Int J Immunogenet. 2006;33:73-9 pubmed
  286. Zhao D, Thornton A, DiPaolo R, Shevach E. Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood. 2006;107:3925-32 pubmed
  287. Yang T, Millar J, Groves T, Grinshtein N, Parsons R, Takenaka S, et al. The CD8+ T cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunity. J Immunol. 2006;176:200-10 pubmed
  288. Matsuda J, Zhang Q, Ndonye R, Richardson S, Howell A, Gapin L. T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells. Blood. 2006;107:2797-805 pubmed
  289. Gopcsa L, Banyai A, Jakab K, Kormos L, Tamaska J, Matolcsy A, et al. Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells. Eur J Haematol. 2005;75:346-51 pubmed
  290. Brischwein K, Schlereth B, Guller B, Steiger C, Wolf A, Lutterbuese R, et al. MT110: a novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors. Mol Immunol. 2006;43:1129-43 pubmed
  291. Irwin S, Izzo A, Dow S, Skeiky Y, Reed S, Alderson M, et al. Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein. Infect Immun. 2005;73:5809-16 pubmed
  292. Bratke K, Kuepper M, Bade B, Virchow J, Luttmann W. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood. Eur J Immunol. 2005;35:2608-16 pubmed
  293. Zelinskyy G, Robertson S, Schimmer S, Messer R, Hasenkrug K, Dittmer U. CD8+ T-cell dysfunction due to cytolytic granule deficiency in persistent Friend retrovirus infection. J Virol. 2005;79:10619-26 pubmed
  294. Klebanoff C, Gattinoni L, Torabi Parizi P, Kerstann K, Cardones A, Finkelstein S, et al. Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci U S A. 2005;102:9571-6 pubmed
  295. Grossman W, Radhi M, Schauer D, Gerday E, Grose C, Goldman F. Development of hemophagocytic lymphohistiocytosis in triplets infected with HHV-8. Blood. 2005;106:1203-6 pubmed
  296. Lang A, Nikolich Zugich J. Development and migration of protective CD8+ T cells into the nervous system following ocular herpes simplex virus-1 infection. J Immunol. 2005;174:2919-25 pubmed
  297. Gondek D, Lu L, Quezada S, Sakaguchi S, Noelle R. Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol. 2005;174:1783-6 pubmed
  298. Quemeneur L, Beloeil L, Michallet M, Angelov G, Tomkowiak M, Revillard J, et al. Restriction of de novo nucleotide biosynthesis interferes with clonal expansion and differentiation into effector and memory CD8 T cells. J Immunol. 2004;173:4945-52 pubmed
  299. Metkar S, Froelich C. Human neutrophils lack granzyme A, granzyme B, and perforin. Blood. 2004;104:905-6; author reply 907-8 pubmed
  300. Grossman W, Verbsky J, Tollefsen B, Kemper C, Atkinson J, Ley T. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood. 2004;104:2840-8 pubmed
  301. Byers A, Kemball C, Moser J, Lukacher A. Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells. J Immunol. 2003;171:17-21 pubmed
  302. McIlroy D, Cartron P, Tuffery P, Dudoit Y, Samri A, Autran B, et al. A triple-mutated allele of granzyme B incapable of inducing apoptosis. Proc Natl Acad Sci U S A. 2003;100:2562-7 pubmed
  303. Kummer J, Kamp A, Tadema T, Vos W, Meijer C, Hack C. Localization and identification of granzymes A and B-expressing cells in normal human lymphoid tissue and peripheral blood. Clin Exp Immunol. 1995;100:164-72 pubmed